US6630328B2
(en)
|
1909-07-15 |
2003-10-07 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms
|
USRE31006E
(en)
*
|
1968-09-24 |
1982-08-03 |
Akzona Incorporated |
Process for the demonstration and determination of reaction components having specific binding affinity for each other
|
US4282325A
(en)
*
|
1971-05-14 |
1981-08-04 |
Syva Company |
Enzyme bound corticosteroids
|
US4046636A
(en)
*
|
1974-06-20 |
1977-09-06 |
Syva Company |
Diazepam enzyme conjugates
|
US4203802A
(en)
*
|
1971-05-14 |
1980-05-20 |
Syva Company |
Inhibitable enzyme amplification assay
|
US4191613A
(en)
*
|
1971-05-14 |
1980-03-04 |
Syva Company |
Malate dehydrogenase conjugates for enzyme immunoassays
|
US3905871A
(en)
*
|
1971-05-14 |
1975-09-16 |
Syva Co |
Lactam conjugates to enzymes
|
US4039385A
(en)
*
|
1972-05-08 |
1977-08-02 |
Syva Company |
Cardiac glycoside enzyme conjugates
|
NL171930C
(nl)
*
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
|
US3790447A
(en)
*
|
1972-07-05 |
1974-02-05 |
Abbott Lab |
Streptococci diagnostic method
|
US3966556A
(en)
*
|
1972-11-06 |
1976-06-29 |
Syva Company |
Compounds for enzyme amplification assay methadone analogs
|
US3975237A
(en)
*
|
1972-11-06 |
1976-08-17 |
Syva Company |
Compounds for enzyme amplification assay - - ecgonine analogs
|
US4040907A
(en)
*
|
1974-06-20 |
1977-08-09 |
Syva Company |
Iodothyronine enzyme conjugates
|
US4061466A
(en)
*
|
1974-10-16 |
1977-12-06 |
Ingvar Gosta Holger Sjoholm |
Biologically active composition and the use thereof
|
NL7501215A
(nl)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
Methode voor het aantonen en bepalen van een antigeen of antilichaam.
|
US4043872A
(en)
*
|
1975-02-20 |
1977-08-23 |
Syva Company |
Polyiodothyronine immunoassay
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4096138A
(en)
*
|
1975-12-08 |
1978-06-20 |
Scherr George H |
Immunological test procedure
|
US4166767A
(en)
*
|
1976-03-25 |
1979-09-04 |
Dainippon Pharmaceutical Co., Ltd. |
Insolubilized antibody
|
JPS5341420A
(en)
*
|
1976-09-29 |
1978-04-14 |
Mochida Pharm Co Ltd |
Immunochemically measuring methoa of hapten
|
GB1572220A
(en)
*
|
1976-10-07 |
1980-07-30 |
Mochida Pharm Co Ltd |
Immunochemical process of measuring physiologically active substances
|
US4098876A
(en)
*
|
1976-10-26 |
1978-07-04 |
Corning Glass Works |
Reverse sandwich immunoassay
|
US4134792A
(en)
*
|
1976-12-06 |
1979-01-16 |
Miles Laboratories, Inc. |
Specific binding assay with an enzyme modulator as a labeling substance
|
IT1153999B
(it)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
|
IL51667A
(en)
*
|
1977-03-16 |
1979-10-31 |
Miles Yeda Ltd |
Immunoassay for the determination of a hapten
|
US4156081A
(en)
*
|
1977-04-15 |
1979-05-22 |
Syva Company |
Theophylline antigens and antibodies
|
IT1114861B
(it)
*
|
1977-05-12 |
1986-01-27 |
Sclavo Inst Sieroterapeut |
Metodo per la determinazione del contenuto di costituenti di fluidi biologici e mezzi adatti allo scopo
|
US5605800A
(en)
*
|
1978-04-13 |
1997-02-25 |
Institut Pasteur |
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
|
FR2422956A1
(fr)
*
|
1978-04-13 |
1979-11-09 |
Pasteur Institut |
Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
|
DE2825650C3
(de)
*
|
1978-06-12 |
1981-02-05 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren zur Bestimmung des Thyroxin-bindungsindex im Serum
|
US4269938A
(en)
*
|
1979-03-08 |
1981-05-26 |
Eastman Kodak Company |
Assay of peroxidatively active materials
|
US4376825A
(en)
*
|
1979-05-07 |
1983-03-15 |
Syva Company |
Enzyme amplification compounds for assays for androgens
|
JPS55152459A
(en)
*
|
1979-05-18 |
1980-11-27 |
Yamasa Shoyu Co Ltd |
Method and reagent for measuring quantity of cyclic nucleotide
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
US4299916A
(en)
*
|
1979-12-26 |
1981-11-10 |
Syva Company |
Preferential signal production on a surface in immunoassays
|
US4391904A
(en)
*
|
1979-12-26 |
1983-07-05 |
Syva Company |
Test strip kits in immunoassays and compositions therein
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
JPS5714748A
(en)
*
|
1980-07-01 |
1982-01-26 |
Dainippon Pharmaceut Co Ltd |
Kit for quantitative determination of valproic acid and its method for quantitative determination
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
DE3265823D1
(en)
*
|
1981-06-02 |
1985-10-03 |
Electro Nucleonics |
Immunoprecipitation assay
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
US5703206A
(en)
*
|
1981-09-08 |
1997-12-30 |
Univ Rockefeller |
Macrophage inflammatory protein 2 (MIP-2)
|
US4419453A
(en)
*
|
1981-09-28 |
1983-12-06 |
The Dow Chemical Company |
Immunological agglutination assays with dyed or colored latex and kits
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4535057A
(en)
*
|
1982-07-26 |
1985-08-13 |
Amf Incorporated |
Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
|
US4530900A
(en)
*
|
1982-09-13 |
1985-07-23 |
Seragen Diagnostics Inc. |
Soluble insoluble polymers in enzymeimmunoassay
|
ZA841924B
(en)
*
|
1983-07-25 |
1984-10-31 |
Becton Dickinson Co |
Chromogenic tracers for use in an assay
|
WO1985000605A1
(en)
*
|
1983-07-27 |
1985-02-14 |
American Hospital Supply Corporation |
Process for selective nitrile reduction
|
FR2550799B1
(fr)
*
|
1983-08-17 |
1986-02-21 |
Commissariat Energie Atomique |
Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
|
DE3433652A1
(de)
*
|
1984-09-13 |
1986-03-20 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Immunchemisches messverfahren fuer haptene und proteine
|
US4713347A
(en)
*
|
1985-01-14 |
1987-12-15 |
Sensor Diagnostics, Inc. |
Measurement of ligand/anti-ligand interactions using bulk conductance
|
US4786594A
(en)
*
|
1986-05-14 |
1988-11-22 |
Syntex (U.S.A.) Inc. |
Enzyme immunoassay
|
ATE154364T1
(de)
*
|
1988-09-02 |
1997-06-15 |
Univ Rockefeller |
Makrophagenabgeleiteter entzündungsmediator(mip- 2)
|
EP0703296B1
(en)
|
1988-09-29 |
1998-07-22 |
Chiron Corporation |
Polynucleotide determination by displacement of a strand on a capture probe
|
CA2031109C
(en)
*
|
1990-07-27 |
1992-01-28 |
Susan J. Danielson |
Ligand analogs for immunoassays derived from dicarboxylic acid oxidation products
|
CA2029006C
(en)
*
|
1990-07-27 |
2001-07-17 |
Michael R. Detty |
Dicarboxylic acid oxidation products
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
US5268298A
(en)
*
|
1991-04-26 |
1993-12-07 |
Life Technologies, Inc. |
System for delivering oxygen to a cell culture medium
|
US5965379A
(en)
*
|
1991-07-19 |
1999-10-12 |
Cytimmune Sciences Inc. |
Method for measuring endogenous cytokines
|
JP3183666B2
(ja)
*
|
1991-07-19 |
2001-07-09 |
アツセイ・リサーチ・インコーポレーテツド |
内因性サイトカイン類の測定方法およびキット
|
US5464749A
(en)
|
1991-07-22 |
1995-11-07 |
Bayer Corporation |
Immunoassay of free substances in biological fluids
|
US5939524A
(en)
*
|
1991-12-09 |
1999-08-17 |
The Scripps Research Institute |
Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use
|
US5624804A
(en)
*
|
1991-12-20 |
1997-04-29 |
The Rockefeller University |
Immunochemical detection of In vivo advanced glycosylation end products
|
US5354692A
(en)
*
|
1992-09-08 |
1994-10-11 |
Pacific Biotech, Inc. |
Analyte detection device including a hydrophobic barrier for improved fluid flow
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US7060283B1
(en)
|
1992-09-15 |
2006-06-13 |
Ortho Diagnostic Systems, Inc. |
Immunoreactive peptides from Epstein-Barr virus
|
US7326535B2
(en)
*
|
1993-09-15 |
2008-02-05 |
Ortho Diagnostic Systems Inc. |
Immunoreactive peptides from Epstein-Barr virus
|
US5637467A
(en)
*
|
1992-10-13 |
1997-06-10 |
Behringwerke Ag |
Heterogeneous assay using a pendulous drop
|
US6953573B1
(en)
|
1993-03-17 |
2005-10-11 |
University Of Washington |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
US5869445A
(en)
*
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
US5801005A
(en)
*
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
US6562333B1
(en)
|
1993-06-14 |
2003-05-13 |
Schering Corporation |
Purified mammalian CTLA-8 antigens and related reagents
|
US6495343B1
(en)
|
1993-06-18 |
2002-12-17 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CRF receptor(s)
|
US6638905B2
(en)
*
|
1993-06-18 |
2003-10-28 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CFR receptor(s)
|
US5516639A
(en)
*
|
1993-07-22 |
1996-05-14 |
Mayo Foundation For Medical Education And Research |
Antibodies specific for human prostate glandular kallkrein
|
US20040259113A1
(en)
*
|
1993-07-22 |
2004-12-23 |
Mayo Foundation For Medical Education And Research, Hybritech Incorporated |
Method for detection of metastatic prostate cancer
|
US6103237A
(en)
*
|
1993-07-22 |
2000-08-15 |
Hybritech Incorporated |
Stable variant hK2 polypeptide
|
US5684144A
(en)
*
|
1993-07-28 |
1997-11-04 |
University Of North Texas |
Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
|
US6884590B1
(en)
|
1994-02-11 |
2005-04-26 |
Cedars-Sinai Medical Center |
Methods of screening for ulcerative colitis and crohn's disease
|
US5681699A
(en)
*
|
1994-02-11 |
1997-10-28 |
Cedars-Sinai Medical Center |
Methods of diagnosing ulcerative colitis and Crohn's disease
|
US6335160B1
(en)
*
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
JPH10500294A
(ja)
*
|
1994-05-10 |
1998-01-13 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ |
組換え型hk2ポリペプチド
|
AU2635295A
(en)
*
|
1994-06-13 |
1996-01-05 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US5589344A
(en)
*
|
1994-06-15 |
1996-12-31 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Test kit and method for competitive specific binding assay
|
ATE201445T1
(de)
|
1994-08-12 |
2001-06-15 |
Myriad Genetics Inc |
Mutationen des mit 17q verbundenen ovarial- und brustkrebs empfindlichkeitsgens
|
AU691958B2
(en)
|
1994-08-12 |
1998-05-28 |
Myriad Genetics, Inc. |
17q-linked breast and ovarian cancer susceptibility gene
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
US6124439A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockefeller University |
OB polypeptide antibodies and method of making
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
US6001968A
(en)
*
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
US8236493B2
(en)
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US6974666B1
(en)
*
|
1994-10-21 |
2005-12-13 |
Appymetric, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5633149A
(en)
|
1994-12-07 |
1997-05-27 |
Incyte Pharmaceuticals, Inc. |
Polynucleotide encoding novel chemokine expressed in inflamed adenoid
|
US7005509B1
(en)
|
1995-02-17 |
2006-02-28 |
Incyte Corporation |
Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
|
US6506553B1
(en)
|
1995-03-30 |
2003-01-14 |
Ortho Diagnostics Systems, Inc. |
Method for diagnosis of Epstein-Barr virus associated disease
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5858661A
(en)
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
GB0112226D0
(en)
*
|
2001-05-18 |
2001-07-11 |
Danisco |
Method of improving dough and bread quality
|
WO1997000271A1
(en)
|
1995-06-14 |
1997-01-03 |
The Regents Of The University Of California |
Novel high affinity human antibodies to tumor antigens
|
US5837492A
(en)
|
1995-12-18 |
1998-11-17 |
Myriad Genetics, Inc. |
Chromosome 13-linked breast cancer susceptibility gene
|
ATE230759T1
(de)
|
1995-12-18 |
2003-01-15 |
Myriad Genetics Inc |
Chromosom 13 verbundene brustkrebsempfindlichkeitsgen brca2
|
US7291463B2
(en)
|
1996-01-23 |
2007-11-06 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
EP0880598A4
(en)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
|
US6965020B2
(en)
|
1996-01-23 |
2005-11-15 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US6864059B2
(en)
*
|
1996-01-23 |
2005-03-08 |
Affymetrix, Inc. |
Biotin containing C-glycoside nucleic acid labeling compounds
|
US20040210045A1
(en)
*
|
1996-01-23 |
2004-10-21 |
Mcgall Glenn |
Nucleic acid labeling compounds
|
US7423143B2
(en)
*
|
1996-01-23 |
2008-09-09 |
Affymetrix. Inc. |
Nucleic acid labeling compounds
|
US7282327B2
(en)
*
|
1996-01-23 |
2007-10-16 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US20010018514A1
(en)
*
|
1998-07-31 |
2001-08-30 |
Mcgall Glenn H. |
Nucleic acid labeling compounds
|
AU2189397A
(en)
|
1996-02-08 |
1997-08-28 |
Affymetrix, Inc. |
Chip-based speciation and phenotypic characterization of microorganisms
|
US6924094B1
(en)
|
1996-02-08 |
2005-08-02 |
Affymetrix, Inc. |
Chip-based species identification and phenotypic characterization of microorganisms
|
EP1728875A3
(en)
|
1996-02-08 |
2007-05-09 |
Affymetrix, Inc. |
Chip-based speciation and phenotypic characterization of microorganisms
|
JP2000507245A
(ja)
*
|
1996-03-22 |
2000-06-13 |
ユニバーシティー オブ ジョージア リサーチ ファウンデーション,インコーポレイテッド |
Porphyromonas gingivalisペプチドを含む免疫原性組成物および方法
|
US5882644A
(en)
*
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
US6942862B2
(en)
*
|
1996-04-01 |
2005-09-13 |
University Of Washington |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
|
BR9710811A
(pt)
|
1996-05-22 |
1999-08-17 |
Novopharm Biotech Inc |
Fragmentos de liga-Æo de antigeno que detecta especificamente c-lulas cancerigenas nucleotideos que codificam os fragmentos e o seu uso para a profilaxia e detec-Æo de c-nceres
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
US20050214827A1
(en)
*
|
1996-07-08 |
2005-09-29 |
Burstein Technologies, Inc. |
Assay device and method
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
EP0918845A4
(en)
|
1996-07-08 |
2000-08-30 |
Burstein Lab Inc |
METHOD AND APPARATUS WITH CLIVABLE SIGNAL ELEMENT
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
EP1947183B1
(en)
|
1996-08-16 |
2013-07-17 |
Merck Sharp & Dohme Corp. |
Mammalian cell surface antigens; related reagents
|
US20070299005A1
(en)
*
|
1996-09-24 |
2007-12-27 |
Tanox, Inc. |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
PT932678E
(pt)
|
1996-09-24 |
2006-07-31 |
Tanox Inc |
Familia de genes que codificam peptidos relacionados com apoptose, peptidos por eles codificados e metodos para sua utilizacao
|
US6610839B1
(en)
*
|
1997-08-14 |
2003-08-26 |
Geron Corporation |
Promoter for telomerase reverse transcriptase
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
US6261836B1
(en)
|
1996-10-01 |
2001-07-17 |
Geron Corporation |
Telomerase
|
US6093809A
(en)
|
1996-10-01 |
2000-07-25 |
University Technology Corporation |
Telomerase
|
GB2321642B8
(en)
*
|
1996-10-01 |
2006-08-22 |
Geron Corp |
Human telomerase reverse transcriptase promoter
|
US6475789B1
(en)
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
US6808880B2
(en)
*
|
1996-10-01 |
2004-10-26 |
Geron Corporation |
Method for detecting polynucleotides encoding telomerase
|
GB9907461D0
(en)
|
1999-03-31 |
1999-05-26 |
King S College London |
Neurite regeneration
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
WO1998021367A1
(en)
|
1996-11-15 |
1998-05-22 |
The Board Of Regents Of The University Of Texas System |
Genetic test for equine severe combined immunodeficiency disease
|
EP1114864B9
(en)
|
1996-12-13 |
2013-05-08 |
Schering Corporation |
Mammalian cell surface antigens, related reagents
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
DE69841160D1
(de)
|
1997-02-07 |
2009-10-29 |
Us Gov Health & Human Serv |
Aktivitätsabhänginger neurotropischer faktor iii(adnf iii)
|
US6268165B1
(en)
|
1997-03-19 |
2001-07-31 |
The Board Of Trustees Of The University Of Arkansas |
Methods for the early diagnosis of ovarian cancer
|
JP4156038B2
(ja)
*
|
1997-04-01 |
2008-09-24 |
カリックス セラピューティックス インコーポレイテッド |
ニガウリの経口活性画分、その活性ペプチドおよび糖尿病治療におけるその使用
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
US20050013825A1
(en)
*
|
1997-04-18 |
2005-01-20 |
Geron Corporation |
Vaccine containing the catalytic subunit of telomerase for treating cancer
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
SK146599A3
(en)
|
1997-05-07 |
2000-07-11 |
Schering Corp |
Essentially pure or recombinant protein dtlr2-10, a fused protein, a bond substance, a nucleic acid, an expression vector, a host cell and process for their production
|
US7115722B1
(en)
|
1997-05-22 |
2006-10-03 |
Viventia Biotech, Inc. |
Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
US6528271B1
(en)
*
|
1997-06-05 |
2003-03-04 |
Duke University |
Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
|
US5891646A
(en)
*
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
US7541151B2
(en)
|
1997-06-05 |
2009-06-02 |
Duke University |
Single-cell biosensor for the measurement of GPCR ligands in a test sample
|
AU8259798A
(en)
|
1997-06-20 |
1999-01-04 |
George G Klee |
Method for detection of breast cancer
|
US20020122807A1
(en)
*
|
1998-07-07 |
2002-09-05 |
Dan Michael D. |
Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
AR014891A1
(es)
|
1997-07-09 |
2001-04-11 |
Schering Corp |
Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
|
WO1999002721A1
(en)
|
1997-07-11 |
1999-01-21 |
University Of North Texas |
THE ESCHERICHIA COLI csrB GENE, RNA ENCODED THEREBY, AND METHODS OF USE THEREOF
|
US6506579B1
(en)
|
1997-07-15 |
2003-01-14 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms using SecG
|
US6762039B2
(en)
*
|
1997-07-15 |
2004-07-13 |
Genencor International, Inc. |
Bacillus subtillis with an inactivated cysteine protease-1
|
US20030157642A1
(en)
|
1997-07-15 |
2003-08-21 |
Caldwell Robert M. |
Increasing production of proteins in gram-positive microorganisms
|
US6723550B1
(en)
*
|
1997-07-15 |
2004-04-20 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US6521421B1
(en)
*
|
1997-07-16 |
2003-02-18 |
Genencor International, Inc. |
Expression vectors encoding Bacillus subtilis disulfide bond isomerase and methods of secreting proteins in gram-positive microorganisms using the same
|
PE20000183A1
(es)
|
1997-07-25 |
2000-03-11 |
Schering Corp |
Citoquinas de mamiferos y reactivos relacionados
|
US6180411B1
(en)
|
1997-08-01 |
2001-01-30 |
The Regents Of The University Of California |
Light-triggered indicators that memorize analyte concentrations
|
EP1798287A3
(en)
|
1997-08-01 |
2007-11-14 |
Schering Corporation |
Mammalian cell membrane proteins and related reagents
|
US7252950B1
(en)
*
|
1997-09-04 |
2007-08-07 |
The Regents Of The University Of California |
Assays for detecting modulators of cytoskeletal function
|
US6521440B1
(en)
*
|
1997-09-15 |
2003-02-18 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US6300117B1
(en)
*
|
1997-09-15 |
2001-10-09 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US7378244B2
(en)
*
|
1997-10-01 |
2008-05-27 |
Geron Corporation |
Telomerase promoters sequences for screening telomerase modulators
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
AU748467B2
(en)
|
1997-10-17 |
2002-06-06 |
University Of South Florida |
Method to diagnose and monitor cellular immune deficiencies
|
GB9724627D0
(en)
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Gram positive microorganism formate pathway
|
US6316241B1
(en)
*
|
1997-11-20 |
2001-11-13 |
Genencor International, Inc. |
Alpha/beta hydrolase-fold enzymes
|
GB9724629D0
(en)
*
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Alpha/beta hydrolase-fold enzymes
|
US6465186B1
(en)
*
|
1997-12-30 |
2002-10-15 |
Genecor International, Inc. |
Proteases from gram positive organisms
|
GB9727470D0
(en)
*
|
1997-12-30 |
1998-02-25 |
Genencor Int Bv |
Proteases from gram positive organisms
|
US6599731B1
(en)
*
|
1997-12-30 |
2003-07-29 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
US6528255B1
(en)
*
|
1997-12-30 |
2003-03-04 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US6780609B1
(en)
|
1998-10-23 |
2004-08-24 |
Genome Therapeutics Corporation |
High bone mass gene of 1.1q13.3
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6673914B1
(en)
|
1998-01-22 |
2004-01-06 |
John Wayne Cancer Institute |
Human tumor-associated gene
|
AU770896C
(en)
|
1998-09-29 |
2006-09-07 |
Gamida Cell Ltd. |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
US6596501B2
(en)
|
1998-02-23 |
2003-07-22 |
Fred Hutchinson Cancer Research Center |
Method of diagnosing autoimmune disease
|
US6060260A
(en)
*
|
1998-02-27 |
2000-05-09 |
Dade Behring Inc. |
Methods for reducing adsorption in an assay
|
CN1249226C
(zh)
|
1998-03-04 |
2006-04-05 |
金克克国际有限公司 |
支链淀粉酶的修饰形式
|
EP2295978A3
(en)
|
1998-03-20 |
2012-06-06 |
The Curators Of The University Of Missouri |
Early pregnancy diagnosis using PAGs(Pregnancy-associated Glycoproteins)
|
ES2501241T3
(es)
*
|
1998-03-30 |
2014-10-01 |
Orasure Technologies, Inc. |
Dispositivo de recolección para análisis de fluidos orales
|
US8062908B2
(en)
*
|
1999-03-29 |
2011-11-22 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
US6303081B1
(en)
*
|
1998-03-30 |
2001-10-16 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
WO1999049774A2
(en)
*
|
1998-03-31 |
1999-10-07 |
Genzyme Corporation |
Methods for the diagnosis and treatment of lung cancer
|
US7108968B2
(en)
*
|
1998-04-03 |
2006-09-19 |
Affymetrix, Inc. |
Mycobacterial rpoB sequences
|
US6699969B1
(en)
|
1998-04-14 |
2004-03-02 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
JP2002522747A
(ja)
|
1998-04-14 |
2002-07-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
微小管脱重合インヒビターを検出するためのアッセイ
|
US6872537B1
(en)
|
1998-04-14 |
2005-03-29 |
Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
AU4994899A
(en)
|
1998-07-13 |
2000-02-01 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
JP2002521666A
(ja)
*
|
1998-07-21 |
2002-07-16 |
バースタイン テクノロジーズ,インコーポレイティド |
光ディスクをベースとするアッセイ装置および方法
|
ATE231186T1
(de)
|
1998-07-21 |
2003-02-15 |
Danisco |
Lebensmittel
|
US6312689B1
(en)
|
1998-07-23 |
2001-11-06 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR2 antibodies and methods of use therefor
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
SE9803099D0
(sv)
|
1998-09-13 |
1998-09-13 |
Karolinska Innovations Ab |
Nucleic acid transfer
|
AU6394399A
(en)
*
|
1998-09-18 |
2000-04-10 |
Rockefeller University, The |
Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof
|
EP1115867A1
(en)
|
1998-09-21 |
2001-07-18 |
Schering Corporation |
Human interleukin-b50. therapeutic uses
|
EP0997476A3
(en)
|
1998-09-25 |
2000-07-19 |
Schering-Plough |
Antibodies to a mammalian Langerhans cell antigen and their uses
|
ES2333694T3
(es)
|
1999-01-11 |
2010-02-26 |
Schering Corporation |
Citoquinas de mamiferos relacionados con la interleuquina-17.polinucleotido que las codifican y sus instalaciones.
|
ES2338405T3
(es)
|
1999-02-04 |
2010-05-07 |
Pluristem Ltd. |
Metodo y aparato para mantenimiento y expasion de celulas madre hemopoyeticas y/o celulas progenitoras.
|
US6156515A
(en)
*
|
1999-02-09 |
2000-12-05 |
Urocor, Inc. |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
|
ATE420894T1
(de)
|
1999-03-11 |
2009-01-15 |
Schering Corp |
Cytokine aus säugetieren, verwandte reagenzien und verfahren
|
AU5007200A
(en)
|
1999-05-13 |
2000-12-05 |
Medical Research Council |
Ox2 receptor homologs
|
AU5011200A
(en)
|
1999-05-14 |
2000-12-05 |
Arbor Vita Corporation |
Molecular interactions in hematopoietic cells
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
DK1181366T4
(da)
|
1999-06-01 |
2013-09-23 |
Merck Sharp & Dohme |
Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
GB9914210D0
(en)
|
1999-06-17 |
1999-08-18 |
Danisco |
Promoter
|
EP1374889A1
(en)
*
|
1999-06-25 |
2004-01-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inducing angiogenesis by micro-organs
|
US6531130B1
(en)
*
|
1999-07-06 |
2003-03-11 |
The Board Of Trustees Of The Leland Stanford University |
Treatment of demyelinating autoimmune disease with ordered peptides
|
MXPA02001146A
(es)
|
1999-07-30 |
2002-08-20 |
Schering Corp |
Citosinas de mamifero, reactivos relacionados.
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7811981B2
(en)
*
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
EP1905832A3
(en)
|
1999-09-09 |
2009-09-09 |
Schering Corporation |
Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
|
EP1903107A1
(en)
|
1999-09-24 |
2008-03-26 |
Cybios LLC |
Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US20030190644A1
(en)
|
1999-10-13 |
2003-10-09 |
Andreas Braun |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US7030228B1
(en)
*
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
ES2272333T3
(es)
|
1999-11-19 |
2007-05-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Procedimiento para aumentar el nivel de una sustancia de fermentacion.
|
WO2001038352A2
(en)
|
1999-11-24 |
2001-05-31 |
Schering Corporation |
Methods of inhibiting metastasis
|
MXPA02005559A
(es)
|
1999-12-06 |
2004-09-10 |
Univ Illinois |
Proteinas de tcr de alta afinidad y metodos.
|
US6544792B1
(en)
|
1999-12-21 |
2003-04-08 |
Genencor International, Inc. |
Production of secreted polypeptides
|
US6544506B2
(en)
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
WO2001053323A2
(en)
*
|
2000-01-24 |
2001-07-26 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
DE10003734A1
(de)
*
|
2000-01-28 |
2001-08-02 |
Bosch Gmbh Robert |
Detektionsverfahren und -vorrichtung
|
DE60131146T2
(de)
*
|
2000-02-25 |
2008-03-06 |
Ludwig Institute For Cancer Research |
Material und verfahren die hybridvaskularendothelwachstumfaktoren dns und proteine enthalten und screeningverfahren für modulatoren
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US8288128B2
(en)
*
|
2004-11-18 |
2012-10-16 |
Eppendorf Array Technologies S.A. |
Real-time quantification of multiple targets on a micro-array
|
US7829313B2
(en)
*
|
2000-03-24 |
2010-11-09 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
US7875442B2
(en)
*
|
2000-03-24 |
2011-01-25 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
IL151860A0
(en)
|
2000-03-27 |
2003-04-10 |
Technion Res & Dev Foundation |
Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
IL151940A0
(en)
|
2000-03-31 |
2003-04-10 |
Scripps Research Inst |
HUMAN AMINOACYL-tRNA SYNTHETASE POLYPETIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
|
US20030108927A1
(en)
*
|
2000-04-03 |
2003-06-12 |
Kathryn Leishman |
Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
|
EP2389943A1
(en)
|
2000-04-18 |
2011-11-30 |
Schering Corporation |
Use of IL-174 antagonists for treating Th2-related diseases
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
US7422743B2
(en)
|
2000-05-10 |
2008-09-09 |
Schering Corporation |
Mammalian receptor protein DCRS5;methods of treatment
|
ES2307618T3
(es)
|
2000-05-10 |
2008-12-01 |
Schering Corporation |
Proteinas subunidades de receptores de cotocinas de mamiferos, reactivos y metodos relacionados.
|
EP1283849A2
(en)
|
2000-05-25 |
2003-02-19 |
Schering Corporation |
Human receptor proteins; related reagents and methods
|
WO2005000087A2
(en)
*
|
2003-06-03 |
2005-01-06 |
Chiron Corporation |
Gene products differentially expressed in cancerous colon cells and their methods of use ii
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
US6958214B2
(en)
*
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
EP2078531B1
(en)
|
2000-08-08 |
2012-05-30 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis
|
US20030114410A1
(en)
*
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
EP1810978B1
(en)
|
2000-08-08 |
2013-02-13 |
St. Jude Children's Research Hospital |
Group B streptococcus polypeptides nucleic acids and therapeutic composition and vaccines thereof
|
GB0020498D0
(en)
|
2000-08-18 |
2000-10-11 |
Sterix Ltd |
Compound
|
EP1683874A3
(en)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
|
EP2028187A1
(en)
|
2000-09-08 |
2009-02-25 |
Board Of Regents, The University Of Texas System |
Human and mouse targeting peptides identified by phage display
|
EP2298789B1
(en)
|
2000-09-08 |
2012-03-14 |
Schering Corporation |
Mammalian genes; related reagents and methods
|
US6673623B1
(en)
|
2000-09-12 |
2004-01-06 |
Novocure, Inc. |
Methods and compositions that control lipid production
|
EP1356060B1
(en)
*
|
2000-09-18 |
2005-12-14 |
Genencor International, Inc. |
Twin-arginine translocation in bacillus
|
US7632522B2
(en)
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
IL155097A0
(en)
*
|
2000-09-28 |
2003-10-31 |
Nanocyte Inc |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
US7045283B2
(en)
|
2000-10-18 |
2006-05-16 |
The Regents Of The University Of California |
Methods of high-throughput screening for internalizing antibodies
|
US7163800B2
(en)
*
|
2000-11-03 |
2007-01-16 |
Molecular Devices Corporation |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
US7018812B2
(en)
|
2000-11-03 |
2006-03-28 |
Duke University |
Modified G-protein coupled receptors
|
US20050136431A1
(en)
*
|
2000-11-03 |
2005-06-23 |
Oakley Robert H. |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
US6890734B2
(en)
|
2000-11-10 |
2005-05-10 |
Schering Corporation |
Nucleic acids encoding a cytokine receptor complex
|
ES2338529T3
(es)
|
2000-11-17 |
2010-05-10 |
Vascular Biogenics Ltd. |
Prometores que exiben especificidad por celulas endoteliales y metodos para su utilizacion.
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
JP4162486B2
(ja)
|
2000-11-24 |
2008-10-08 |
ヴァスキュラー バイオジェニックス リミテッド |
アテローム性動脈硬化を防止および処置するための規定された酸化型リン脂質を用いる方法およびそのような酸化型リン脂質を含有する組成物
|
US20030003464A1
(en)
*
|
2000-11-27 |
2003-01-02 |
Phan Brigitte C. |
Dual bead assays including optical biodiscs and methods relating thereto
|
US20040248093A1
(en)
*
|
2000-11-27 |
2004-12-09 |
Coombs James Howard |
Magneto-optical bio-discs and systems including related methods
|
US20020172980A1
(en)
*
|
2000-11-27 |
2002-11-21 |
Phan Brigitte Chau |
Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
|
EP1337640A2
(en)
*
|
2000-11-29 |
2003-08-27 |
Lynkeus Bio Tech GmbH |
NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
|
IL155941A0
(en)
*
|
2000-11-30 |
2003-12-23 |
Yeda Res & Dev |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
WO2002044736A2
(en)
|
2000-11-30 |
2002-06-06 |
Molecular Skincare Limited |
Diagnosis and treatment of epidermal or skin diseases
|
AU2002220275A1
(en)
*
|
2000-12-08 |
2002-06-18 |
The Board Of Trustees Of The University Of Illinois |
Mutated class ii major histocompatibility proteins
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
GB0101762D0
(en)
*
|
2001-01-23 |
2001-03-07 |
Medical Res Council |
Method
|
US20050031618A1
(en)
*
|
2001-01-31 |
2005-02-10 |
Dror Mevorach |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20050202098A1
(en)
*
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
JP2004537506A
(ja)
|
2001-03-01 |
2004-12-16 |
ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド |
血液細胞欠乏症を治療するためのある種のステロイドの使用
|
EP1385829A4
(en)
*
|
2001-03-12 |
2005-10-19 |
Affymetrix Inc |
NUCLEIC ACID MARKING COMPOUNDS
|
US20030104410A1
(en)
*
|
2001-03-16 |
2003-06-05 |
Affymetrix, Inc. |
Human microarray
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US20030220475A1
(en)
*
|
2001-04-03 |
2003-11-27 |
Fields Howard A. |
Neutralizing immunogenic hev polypepetides
|
US7618789B2
(en)
*
|
2001-04-06 |
2009-11-17 |
The United States Of America As Represented By The Secretary Of Department Of Health And Human Services |
Use of semenogelin in the diagnosis, prognosis and treatment of cancer
|
US20110313230A1
(en)
|
2001-05-11 |
2011-12-22 |
Terrance Grant Johns |
Specific binding proteins and uses thereof
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
WO2002092771A2
(en)
|
2001-05-11 |
2002-11-21 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
BR0209154A
(pt)
|
2001-05-18 |
2004-07-20 |
Danisco |
Processo de preparação de uma massa com uma enzima
|
CA2448142A1
(en)
|
2001-05-22 |
2002-11-28 |
Merck & Co., Inc. |
Beta-secretase substrates and uses thereof
|
US20090324612A1
(en)
*
|
2001-06-05 |
2009-12-31 |
Kaufman Daniel L |
Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
|
WO2002099069A2
(en)
*
|
2001-06-05 |
2002-12-12 |
The Regents Of The University Of California |
Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
US20070190534A1
(en)
*
|
2001-06-11 |
2007-08-16 |
Genesis Genomics Inc. |
Mitochondrial sites and genes associated with prostate cancer
|
WO2003008534A2
(en)
*
|
2001-07-19 |
2003-01-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
WO2003012030A2
(en)
*
|
2001-08-01 |
2003-02-13 |
University Of Utah, Technology Transfer Office |
Isoform-selective inhibitors and activators of pde3 cyclic
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
AU2003270548B2
(en)
|
2002-09-09 |
2008-09-25 |
Arbor Vita Corporation |
Methods of diagnosing cervical cancer
|
US20030082596A1
(en)
*
|
2001-08-08 |
2003-05-01 |
Michael Mittmann |
Methods of genetic analysis of probes: test3
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
AU2002330724A1
(en)
|
2001-08-16 |
2003-03-10 |
Bar Ilan University |
Diagnosis, prevention and treatment of cancer
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
ATE443259T1
(de)
|
2001-09-20 |
2009-10-15 |
Univ Texas |
Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper- komplexe mit elisa-tests
|
US7393696B2
(en)
*
|
2001-09-28 |
2008-07-01 |
Aspenbio Pharma, Inc. |
Bovine pregnancy test
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
WO2003030835A2
(en)
|
2001-10-12 |
2003-04-17 |
Schering Corporation |
Use of bispecific antibodies to regulate immune responses
|
JP4173446B2
(ja)
|
2001-10-19 |
2008-10-29 |
ヴァスキュラー バイオジェニックス リミテッド |
血管形成の標的化されたダウンレギュレーションおよび抗ガン治療のためのポリヌクレオチド構築物および薬学的組成物および方法
|
US7175983B2
(en)
*
|
2001-11-02 |
2007-02-13 |
Abmaxis, Inc. |
Adapter-directed display systems
|
MXPA04004880A
(es)
|
2001-11-20 |
2004-09-03 |
Monsanto Technology Llc |
Composiciones y metodos para el diagnostico temprano y preciso de prenez.
|
US6952704B2
(en)
*
|
2001-11-26 |
2005-10-04 |
Microsoft Corporation |
Extending a directory schema independent of schema modification
|
AU2002358947A1
(en)
*
|
2001-12-05 |
2003-06-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
WO2003054155A2
(en)
*
|
2001-12-19 |
2003-07-03 |
Bristol-Myers Squibb Company |
Pichia pastoris formate dehydrogenase and uses therefor
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
WO2003063110A1
(en)
*
|
2002-01-16 |
2003-07-31 |
Regents Of The University Of Minnesota |
Marker for psychiatric conditions
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(en)
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
CN102659945B
(zh)
|
2002-01-25 |
2016-12-21 |
诺沃挪第克公司 |
抗C5aR抗体及其应用
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
JP2005516606A
(ja)
|
2002-02-01 |
2005-06-09 |
シェーリング コーポレイション |
哺乳動物のサイトカイン;関連する試薬の使用
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
EP1485075A4
(en)
*
|
2002-02-20 |
2006-04-26 |
Dyax Corp |
MHC-PEPTIDE COMPLEX BINDING LIGANDS
|
EP1573035B1
(en)
|
2002-02-22 |
2015-09-02 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
Brother of the regulator of imprinted sites (boris)
|
US7053188B2
(en)
|
2002-02-22 |
2006-05-30 |
Purdue Research Foundation |
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
|
WO2003078567A2
(en)
*
|
2002-03-18 |
2003-09-25 |
Gamida-Cell Ltd. |
Methods of inducing differentiation in ex vivo expanded stem cells
|
US20030182669A1
(en)
*
|
2002-03-19 |
2003-09-25 |
Rockman Howard A. |
Phosphoinositide 3-kinase mediated inhibition of GPCRs
|
DE60320793D1
(de)
*
|
2002-03-26 |
2008-06-19 |
Nanocyte Inc |
Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur ametischen mittels in ein gewebe
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
CA2391438A1
(en)
*
|
2002-05-01 |
2003-11-01 |
Procyon Biopharma Inc. |
Psp94 diagnostic reagents and assays
|
US7534580B2
(en)
*
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
AU2003228809A1
(en)
|
2002-05-03 |
2003-11-17 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof, and related methods
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
ATE474045T1
(de)
|
2002-05-30 |
2010-07-15 |
Sloan Kettering Inst Cancer |
Kinasesuppressor der ras-inaktivierung zur therapie von durch ras vermittelter tumorgenese
|
NZ537328A
(en)
*
|
2002-05-31 |
2008-04-30 |
Genetic Technologies Ltd |
Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
|
US7290215B2
(en)
*
|
2002-06-03 |
2007-10-30 |
Microsoft Corporation |
Dynamic wizard interface system and method
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
JP4570565B2
(ja)
|
2002-07-15 |
2010-10-27 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
ペリプラズム発現によるコンビナトリアルタンパク質ライブラリーのスクリーニング
|
ATE491725T1
(de)
|
2002-07-15 |
2011-01-15 |
Univ Texas |
Antikörper mit bindung an anionische phospholipide und aminophospholipide und ihre verwendung bei der behandlung von virusinfektionen
|
US7794716B2
(en)
|
2002-07-25 |
2010-09-14 |
Glenveigh Pharmaceuticals, Llc |
Antibody composition and passive immunization against pregnancy-induced hypertension
|
EP1524989B1
(en)
|
2002-08-01 |
2013-11-06 |
Yeda Research And Development Co., Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
EA200500330A1
(ru)
*
|
2002-08-10 |
2006-06-30 |
Йейл Юниверсити |
Антагонисты nogo рецепторов
|
EP2298315A1
(en)
|
2002-08-28 |
2011-03-23 |
Harbor BioSciences, Inc. |
Therapeutic treatment methods
|
EP2371955A1
(en)
|
2002-09-26 |
2011-10-05 |
K.U. Leuven Research & Development |
Integrase cofactor
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
EP1556040A1
(en)
|
2002-10-24 |
2005-07-27 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
AU2003284968A1
(en)
*
|
2002-10-25 |
2004-05-13 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
AU2003278578A1
(en)
|
2002-10-30 |
2004-05-25 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Molecules and methods using same for measuring non-transferrin bound iron
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
DK1567117T3
(da)
|
2002-11-26 |
2012-05-21 |
Univ Chicago |
Forebyggelse og behandling af mikrobe-medierede epitelsygdomme
|
AU2003302701A1
(en)
*
|
2002-11-29 |
2004-06-23 |
Technion Research And Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US8323897B2
(en)
|
2002-12-04 |
2012-12-04 |
Applied Biosystems, Llc |
Multiplex amplification of polynucleotides
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
DE60334846D1
(de)
|
2002-12-12 |
2010-12-16 |
R B T Rakuto Bio Technologies |
VERWENDUNG von LIGNINPEROXIDASE ZUR HAUT- UND HAARAUFHELLUNG
|
AU2003303071B2
(en)
|
2002-12-16 |
2009-04-23 |
Technion Research & Development Foundation Ltd. |
Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
|
AU2002953431A0
(en)
*
|
2002-12-19 |
2003-01-09 |
Murdoch University |
BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof
|
EP1587953B1
(en)
|
2003-01-02 |
2012-02-22 |
Rappaport Family Institute for Research in the Medical Sciences |
Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
|
US20040229245A1
(en)
*
|
2003-01-06 |
2004-11-18 |
Anton Bittner |
Methods and algorithms for performing quality control during gene expression profiling on DNA microarray technology
|
ATE426575T1
(de)
|
2003-01-07 |
2009-04-15 |
Univ Ramot |
Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben
|
DE602004030000D1
(de)
*
|
2003-01-17 |
2010-12-23 |
Danisco |
Verfahren zur in-situ-herstellung eines emulgators in einem nahrungsmittel
|
US7955814B2
(en)
|
2003-01-17 |
2011-06-07 |
Danisco A/S |
Method
|
PT1748074E
(pt)
|
2003-01-17 |
2012-01-16 |
Danisco |
Método para a produção in situ de um emulsificador num alimento
|
US20050196766A1
(en)
|
2003-12-24 |
2005-09-08 |
Soe Jorn B. |
Proteins
|
US7615610B2
(en)
*
|
2003-01-24 |
2009-11-10 |
Duke University |
Modified trafficking patterns for arrestin and G-protein-coupled receptors via arrestin-ubiquitin chimera
|
CN101044404A
(zh)
*
|
2003-03-03 |
2007-09-26 |
长冈实业株式会社 |
用于不同类型细胞检测和定量的方法和装置以及生物光盘在该检测和定量中的应用
|
EP1599598A4
(en)
|
2003-03-04 |
2007-08-08 |
Yeda Res & Dev |
PON POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, AND COMPOSITIONS AND METHODS USING THE SAME
|
AU2004217872B2
(en)
*
|
2003-03-05 |
2010-03-25 |
Genetic Technologies Limited |
Identification of fetal DNA and fetal cell markers in maternal plasma or serum
|
WO2004096157A2
(en)
|
2003-03-07 |
2004-11-11 |
New England Medical Center Hospitals, Inc. |
Treatment of igai deposition diseases
|
EP1601759A4
(en)
*
|
2003-03-07 |
2007-02-14 |
Gamida Cell Ltd |
EXPANSION OF RENEWABLE STEM CELL POPULATIONS USING PI-3 KINASE MODULATORS
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
ATE517926T1
(de)
|
2003-04-04 |
2011-08-15 |
Yeda Res & Dev |
Antikörper zur hemmung der aktivität von mmp-2 und mmp-9
|
JP4865540B2
(ja)
|
2003-04-08 |
2012-02-01 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
化学誘引物質に対する増大された感受性を有する幹細胞およびそれを産生および使用する方法
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US20040209246A1
(en)
*
|
2003-04-15 |
2004-10-21 |
Agouron Pharmaceuticals, Inc. |
Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
|
JP2006523708A
(ja)
*
|
2003-04-16 |
2006-10-19 |
イェール ユニバーシティ |
アミロイド斑に関連する状態の処置のためのNogoレセプターアンタゴニスト
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
EP1625199B1
(en)
|
2003-05-22 |
2015-03-11 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
|
US7554007B2
(en)
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
US7498428B2
(en)
*
|
2003-06-19 |
2009-03-03 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP1638517A4
(en)
|
2003-06-30 |
2010-01-06 |
Univ Tel Aviv Future Tech Dev |
PEPTIDES, ANTIBODIES AGAINST DISEASES ASSOCIATED WITH AMYLOID AND METHODS OF USE FOR THE DIAGNOSIS AND TREATMENT OF THESE DISEASES
|
WO2005014795A2
(en)
|
2003-08-08 |
2005-02-17 |
Genenews Inc. |
Osteoarthritis biomarkers and uses thereof
|
US20050064479A1
(en)
*
|
2003-08-12 |
2005-03-24 |
Affymetrix, Inc. |
Compounds and methods for post incorporation labeling of nucleic acids
|
US20080050313A1
(en)
|
2003-08-14 |
2008-02-28 |
Exelixis, Inc. |
Sulfs as Modifiers of the Beta-Catenin Pathway and Methods of Use
|
EP1654348A4
(en)
*
|
2003-08-14 |
2008-02-13 |
Bio Balance Corp |
BACTERIAL STRAINS, COMPOSITIONS AND PROBIOTIC USE THEREOF
|
WO2005029091A2
(en)
|
2003-09-15 |
2005-03-31 |
Oklahoma Medical Research Foundation |
Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
|
US20050064435A1
(en)
*
|
2003-09-24 |
2005-03-24 |
Xing Su |
Programmable molecular barcodes
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
ATE509034T1
(de)
|
2003-10-07 |
2011-05-15 |
Yeda Res & Dev |
Antikörper gegen nik, deren herstellung und verwendung
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
US20050227251A1
(en)
|
2003-10-23 |
2005-10-13 |
Robert Darnell |
Method of purifying RNA binding protein-RNA complexes
|
CA2542221A1
(en)
*
|
2003-10-23 |
2005-05-06 |
Pfizer Products Inc. |
Vaccine for periodontal disease
|
AR046833A1
(es)
|
2003-11-10 |
2005-12-28 |
Schering Corp |
Anticuerpos anti-interleuquina-10
|
US8034340B2
(en)
|
2003-11-30 |
2011-10-11 |
Yeda Research And Development Ltd. |
Method for treating an immune disorder by decreasing NIK-SIVA complex formation
|
JP2007521248A
(ja)
|
2003-12-10 |
2007-08-02 |
ミレニアム ファーマシューティカルズ, インコーポレイテッド |
ヒト化抗ccr2抗体および該抗体を使用する方法
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
EP2289567A3
(en)
|
2003-12-22 |
2011-06-22 |
Regentis Biomaterials Ltd. |
Matrix comprising naturally-occurring crosslinked protein backbone
|
JP5030594B2
(ja)
|
2003-12-23 |
2012-09-19 |
アルボー ビータ コーポレーション |
Hpvの発癌性株に対する抗体およびそれらの使用方法
|
GB0716126D0
(en)
*
|
2007-08-17 |
2007-09-26 |
Danisco |
Process
|
US7718408B2
(en)
*
|
2003-12-24 |
2010-05-18 |
Danisco A/S |
Method
|
BRPI0417533B1
(pt)
|
2003-12-24 |
2016-03-01 |
Danisco |
enzima variante glicolipídio aciltransferase, uso e método para sua produção, método para o preparo de um produto alimentício e produto assado de farinha, processo de refinamento enzimático
|
US8007847B2
(en)
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
US20050186646A1
(en)
*
|
2004-01-26 |
2005-08-25 |
Cruz Miguel A. |
Rapid assay to detect ADAMTS-13 activity
|
WO2005071058A2
(en)
*
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Methods and systems for annotating biomolecular sequences
|
WO2005079316A2
(en)
*
|
2004-02-18 |
2005-09-01 |
Merck & Co., Inc. |
Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
|
US7767792B2
(en)
|
2004-02-20 |
2010-08-03 |
Ludwig Institute For Cancer Research Ltd. |
Antibodies to EGF receptor epitope peptides
|
GB0403864D0
(en)
|
2004-02-20 |
2004-03-24 |
Ucl Ventures |
Modulator
|
EP2208797A3
(en)
|
2004-03-01 |
2010-11-24 |
Applied Biosystems, LLC |
Methods, compositions and kits for use in polynucleotide amplification
|
AU2005219441A1
(en)
|
2004-03-02 |
2005-09-15 |
Acceleron Pharma Inc. |
ALK7 and myostatin inhibitors and uses thereof
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
GB0405637D0
(en)
|
2004-03-12 |
2004-04-21 |
Danisco |
Protein
|
WO2005090406A2
(en)
|
2004-03-12 |
2005-09-29 |
Vasgene Therapeutics, Inc. |
Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
|
US20080206188A1
(en)
*
|
2004-04-20 |
2008-08-28 |
Alverdy John C |
Therapeutic Delivery System Comprising a High Molecular Weight Peg-Like Compound
|
EP2400030B1
(en)
|
2004-05-18 |
2016-01-20 |
The Board of Trustees of the Leland Stanford Junior University |
Detection of protein translocation by beta-galactosidase reporter fragment complementation
|
NZ551627A
(en)
|
2004-05-28 |
2010-02-26 |
Agensys Inc |
Antibodies and related molecules that bind to PSCA proteins
|
BRPI0511395B1
(pt)
|
2004-06-14 |
2019-03-06 |
Evogene Ltd. |
Construção de ácido nucléico, e, método de melhoria do rendimento da fibra de uma planta produtora de fibra
|
US8034553B2
(en)
|
2004-06-24 |
2011-10-11 |
Kimberly-Clark Worldwide, Inc. |
Biomarkers for wound healing
|
ITBO20040412A1
(it)
*
|
2004-07-01 |
2004-10-01 |
Eurodent Spa |
Lampada dentale particolarmente per ambulatori medico-dentistici
|
US8680062B2
(en)
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
DK1791933T3
(da)
|
2004-07-16 |
2011-09-05 |
Danisco |
Fremgangsmåde til enzymatisk afkogning af olie
|
US20090233986A1
(en)
*
|
2004-07-27 |
2009-09-17 |
Mount Sinai School Of Medicine |
Methods and compositions for using sax2
|
EP1789437A4
(en)
*
|
2004-07-30 |
2008-11-05 |
Sinai School Medicine |
INHIBITORS OF NPC1L1 AND NPC1L1 AND METHODS OF USE THEREOF
|
US20060073168A1
(en)
*
|
2004-08-11 |
2006-04-06 |
Stephens David S |
Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions
|
MX2007002294A
(es)
|
2004-08-26 |
2007-10-19 |
Engeneic Molecular Delivery Pty Ltd |
Suministro de acidos nucleicos funcionales a celulas mamiferas via minicelulas intactas, derivadas bacterialmente.
|
FI20050753A
(fi)
|
2004-09-03 |
2006-03-04 |
Licentia Oy |
Uudet peptidit
|
US7678824B2
(en)
|
2004-09-14 |
2010-03-16 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods for treatment with bucindolol based on genetic targeting
|
EP1799812A4
(en)
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
EX VIVO CULTIVATION METHODS OF STEM CELLS AND PRECURSOR BY CO-CULTURE WITH MESENCHYMAL CELLS
|
US10583094B2
(en)
|
2004-09-18 |
2020-03-10 |
University Of Maryland |
Therapeutic methods that target the NCCA-ATP channel
|
ATE487484T1
(de)
|
2004-09-18 |
2010-11-15 |
Univ Maryland |
Therapeutische mittel zum targeting des nc ca-atp-kanals und verwendungsverfahren dafür
|
DK1797127T3
(en)
*
|
2004-09-24 |
2017-10-02 |
Amgen Inc |
Modified Fc molecules
|
ES2524601T3
(es)
*
|
2004-09-29 |
2014-12-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
RNasa T2 humana recombinante y usos de la misma
|
EP3088528B1
(en)
|
2004-09-29 |
2019-07-03 |
Collplant Ltd. |
Collagen producing plants and methods of generating and using same
|
GB0422052D0
(en)
|
2004-10-04 |
2004-11-03 |
Dansico As |
Enzymes
|
US7390489B2
(en)
*
|
2004-10-08 |
2008-06-24 |
Komed Co., Ltd. |
Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody
|
WO2006040765A1
(en)
*
|
2004-10-12 |
2006-04-20 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
GB0423139D0
(en)
|
2004-10-18 |
2004-11-17 |
Danisco |
Enzymes
|
WO2006050270A2
(en)
*
|
2004-11-02 |
2006-05-11 |
The Government Of The United States Of America As Represented By The Secretary Department Of Health & Human Services |
Compositions and methods for treating hyperproliferative disorders
|
GB0424940D0
(en)
|
2004-11-11 |
2004-12-15 |
Danisco |
Transcription factors
|
ATE482288T1
(de)
|
2004-11-18 |
2010-10-15 |
Eppendorf Array Technologies |
Echtzeit-pcr von zielen auf einem mikroarray
|
EP2283831A3
(en)
|
2004-12-03 |
2013-10-23 |
Merck Sharp & Dohme Corp. |
Biomakers for pre-selection of patients for anti-IGF1R therapy
|
WO2008109782A2
(en)
*
|
2007-03-06 |
2008-09-12 |
Cedars-Sinai Medical Center |
Diagnosis of inflammatory bowel disease in children
|
US7504769B2
(en)
*
|
2004-12-16 |
2009-03-17 |
E. I. Du Pont De Nemours + Company |
Aromatic chalcogen compounds and their use
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
EP1844403A4
(en)
|
2005-01-16 |
2010-06-23 |
Zlango Ltd |
SIGNS COMMUNICATION
|
EP1872604A4
(en)
*
|
2005-01-16 |
2010-01-20 |
Zlango Ltd |
COMMUNICATION NETWORK SYSTEM AND METHODS OF USE
|
WO2006080021A2
(en)
|
2005-01-31 |
2006-08-03 |
Realbio Technologies Ltd. |
Multistep reaction lateral flow capillary device
|
CN101495498B
(zh)
|
2005-02-07 |
2013-09-18 |
基因信息公司 |
轻度骨关节炎生物标志物及其用途
|
CA2597699C
(en)
|
2005-02-17 |
2012-07-31 |
Hadasit Medical Research Services And Development Ltd. |
Bisphosphonates for treating endometriosis
|
GB0503546D0
(en)
*
|
2005-02-21 |
2005-03-30 |
Hellenic Pasteur Inst |
Antibody
|
EP1871402B1
(en)
|
2005-02-25 |
2017-07-26 |
State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center |
Grape cell culture for treating inflammation
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
EP2444099A1
(en)
|
2005-03-31 |
2012-04-25 |
Agensys, Inc. |
Antibodies and related molecules that bind to 161P2F10B proteins
|
DK2645106T3
(en)
|
2005-04-04 |
2017-10-02 |
Biogen Ma Inc |
Methods for Evaluating an Immune Response to a Therapeutic Agent
|
US20090068207A1
(en)
*
|
2005-04-15 |
2009-03-12 |
Vascular Biogenics Ltd. |
Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease
|
US20130022979A1
(en)
|
2005-04-18 |
2013-01-24 |
Genesis Genomics Inc. |
3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
|
AU2006238390B2
(en)
|
2005-04-18 |
2011-07-28 |
Mitomics Inc. |
Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
AR053385A1
(es)
|
2005-05-12 |
2007-05-02 |
Novartis Ag |
Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia
|
WO2006126208A2
(en)
|
2005-05-26 |
2006-11-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
DK1893747T3
(en)
|
2005-06-16 |
2014-12-01 |
Univ Ramot |
ISOLATED CELLS AND POPULATIONS INCLUDING SUCH CELLS FOR TREATING CNS DISEASES
|
CN104673903B
(zh)
|
2005-06-20 |
2018-11-13 |
领先细胞医疗诊断有限公司 |
检测单个细胞中的核酸和鉴定异质大细胞群中罕见细胞的方法
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
CN101273130B
(zh)
*
|
2005-07-07 |
2012-05-30 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于下调h19的核酸物质及其使用方法
|
EP1904526A4
(en)
|
2005-07-07 |
2009-10-28 |
Fulcrum Sp Ltd |
SP1-POLYPEPTIDES, MODIFIED SP1-POLYPEPTIDES AND APPLICATIONS THEREOF
|
BRPI0616012A2
(pt)
|
2005-07-18 |
2011-05-31 |
Protalix Ltd |
administração via mucosa ou intestino de macromoléculas biologicamente ativas
|
EP2889041A1
(en)
|
2005-07-26 |
2015-07-01 |
Rutgers, The State University of New Jersey |
Kit of reagents for tuberculosis assay
|
WO2007019541A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Onconon, Llc. |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
EP1928479B1
(en)
|
2005-08-24 |
2016-06-08 |
Yeda Research And Development Co., Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
EP1962719A4
(en)
|
2005-08-29 |
2011-05-04 |
Technion Res And Dev Of Foundation Ltd |
MEDIA FOR BREEDING STEM CELLS
|
EP3190125A1
(en)
|
2005-08-31 |
2017-07-12 |
Merck Sharp & Dohme Corp. |
Engineered anti-il-23 antibodies
|
US7608395B2
(en)
*
|
2005-09-15 |
2009-10-27 |
Baylor Research Institute |
Systemic lupus erythematosus diagnostic assay
|
JP2009508516A
(ja)
|
2005-09-22 |
2009-03-05 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム |
核酸構築物、薬剤組成物、及び癌治療のためのその使用方法
|
WO2007041340A2
(en)
*
|
2005-09-30 |
2007-04-12 |
The Trustees Of Columbia University In The City Of New York |
Microfluidic cells with parallel arrays of individual dna molecules
|
WO2007047408A2
(en)
*
|
2005-10-12 |
2007-04-26 |
Pathologica, Llc. |
Promac signature application
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
CA2626604A1
(en)
|
2005-10-21 |
2007-04-26 |
Genenews Inc. |
Method and apparatus for correlating levels of biomarker products with disease
|
AU2006307457B2
(en)
|
2005-10-24 |
2012-03-22 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same
|
US7842823B2
(en)
*
|
2005-10-27 |
2010-11-30 |
The Regents Of The University Of California |
Fluorogenic probes for reactive oxygen species
|
EP2395012B8
(en)
|
2005-11-02 |
2018-06-06 |
Arbutus Biopharma Corporation |
Modified siRNA molecules and uses thereof
|
CA2628238A1
(en)
|
2005-11-07 |
2007-05-18 |
The Scripps Research Institute |
Compositions and methods for controlling tissue factor signaling specificity
|
DE212006000071U1
(de)
|
2005-11-18 |
2008-07-24 |
Board of Regents, The University of Texas System, Austin |
Quantifizierung von Fusionsproteinen und ihrer Aktivität in Folge chromosomaler Translokation
|
KR20080072748A
(ko)
|
2005-11-29 |
2008-08-06 |
가미다-셀 리미티드 |
줄기세포 귀소 및 생착을 향상시키는 방법
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
KR20080080525A
(ko)
|
2005-12-08 |
2008-09-04 |
노파르티스 아게 |
유전자 전사에 대한 fgfr3의 억제제의 효과
|
US20070134814A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Kajander E O |
Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
|
EP2674440B1
(en)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Multivalent immunoglobulin-based bioactive assemblies
|
EP1976869A2
(en)
|
2005-12-23 |
2008-10-08 |
Partnership&Corp. Technology Transfer |
Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
|
US7465544B2
(en)
*
|
2006-01-11 |
2008-12-16 |
Wisconsin Alumni Research Foundation |
Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
|
WO2007080559A2
(en)
|
2006-01-16 |
2007-07-19 |
Zlango Ltd. |
Iconic communication
|
EP1982450A2
(en)
*
|
2006-01-16 |
2008-10-22 |
Zlango Ltd. |
Communications network system and methods for using same
|
EP1981902B1
(en)
|
2006-01-27 |
2015-07-29 |
Biogen MA Inc. |
Nogo receptor antagonists
|
US20070179094A1
(en)
|
2006-01-31 |
2007-08-02 |
Bayer Schering Pharma Ag |
Modulation of MDL-1 activity for treatment of inflammatory disease
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US7553940B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting EPO polypeptides and derivatives thereof and methods thereof
|
BRPI0706967A2
(pt)
|
2006-02-06 |
2011-04-12 |
Rappaport Family Inst For Res |
método e kit para diagnosticar dmt1
|
SI1986661T1
(sl)
|
2006-02-08 |
2018-12-31 |
Genzyme Corporation |
Genska terapija za Niemann-Pickovo bolezen tipa A
|
KR20080114689A
(ko)
|
2006-02-09 |
2008-12-31 |
유니버시티 오브 사우스 플로리다 |
증가된 bcl-2에 의한 암의 발견
|
DK2676967T3
(da)
|
2006-02-28 |
2019-09-16 |
Biogen Ma Inc |
Fremgangsmåder til behandling af inflammatoriske og autoimmune sygdomme med natalizumab
|
MX2008011176A
(es)
|
2006-03-03 |
2008-09-10 |
Elan Pharm Inc |
Metodos para tratar padecimientos inflamatorios y autoinmunes con natalizumab.
|
AU2007224386B2
(en)
|
2006-03-06 |
2013-12-19 |
Zetiq Technologies Ltd. |
Methods and compositions for identifying a cell phenotype
|
WO2007109733A2
(en)
|
2006-03-21 |
2007-09-27 |
The Johns Hopkins University |
Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
|
EP2626417B1
(en)
|
2006-03-23 |
2015-09-02 |
Pluristem Ltd. |
Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
|
EP2004858A4
(en)
|
2006-03-28 |
2009-12-09 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
METHOD AND KITS FOR DETERMINING AN INVESTMENT TO WARFARINE RESISTANCE
|
US20070232556A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Montine Thomas J |
Methods and compositions for the treatment of neurological diseases and disorders
|
BRPI0709481A2
(pt)
*
|
2006-04-07 |
2011-07-19 |
Government Of The Us Secretary Dept Of Health And Human Services |
anticorpo monoclonal isolado, anticorpo monoclonal humano isolado, composição farmacêutica, anticorpo anti-igf-i e anti-igf-ii recombinante isolado ou fragmento de ligação ao antìgeno do mesmo, método para detectar o fator i e o fator ii de crescimento insulina humana em uma amostra, método para dectetar o fator i de crescimento insulina humana em uma amostra, ácido nucléico isolado, célula recombinante , célula hospedeira ,método para preparar um anticorpo, método para preparar um anticorpo, método para tratar uma doença neoplásica em um indivìduo mamìfero, método para diagnosticar doença neoplásica em um indivìduo mamìfero e método para classificar um composto candidato a fármaco
|
WO2007121522A1
(en)
|
2006-04-21 |
2007-11-01 |
Minister for Primary Industries For And On Behalf Of The State Of New South Wales |
Pestivirus species
|
FR2900341B1
(fr)
|
2006-04-27 |
2012-09-14 |
Centre Nat Rech Scient |
Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer
|
US8790871B2
(en)
*
|
2006-05-09 |
2014-07-29 |
Musc Foundation For Research Development |
Detecting diastolic heart failure by protease and protease inhibitor plasma profiling
|
MX2008014722A
(es)
*
|
2006-05-19 |
2011-04-15 |
Teva Pharma |
Proteinas de fusion, usos de las mismas y procesos para producir las mismas.
|
US20100196336A1
(en)
|
2006-05-23 |
2010-08-05 |
Dongsu Park |
Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
US20080003230A1
(en)
|
2006-07-03 |
2008-01-03 |
Adair Charles D |
Composition for modulating the expression of cell adhesion molecules
|
US20080026394A1
(en)
*
|
2006-07-11 |
2008-01-31 |
Antara Biosciences Inc. |
Methods of detecting one or more cancer markers
|
RU2009104460A
(ru)
*
|
2006-07-11 |
2010-08-20 |
Маск Фаундейшн Фор Рисерч Дивелопмент (Us) |
Прогнозирование сердечной недостаточности после инфаркта миокарда по профилю протеаз и ингибиторов протеаз
|
JP5266219B2
(ja)
|
2006-07-14 |
2013-08-21 |
ケモセントリックス, インコーポレイテッド |
トリアゾリルフェニルベンゼンスルホンアミド類
|
WO2008010228A2
(en)
|
2006-07-20 |
2008-01-24 |
Yeda Research And Development Co. Ltd. |
Photosyntheticorganisms and compositions and methods of generating same
|
EP2053961A4
(en)
*
|
2006-08-09 |
2013-05-01 |
Biogen Idec Inc |
METHOD FOR DISPENSING A MEDICAMENT
|
WO2008017636A2
(en)
|
2006-08-09 |
2008-02-14 |
Spirogene Pty Ltd |
Genes and proteins of brachyspira hyodysenteriae and uses thereof
|
JP2008043332A
(ja)
|
2006-08-17 |
2008-02-28 |
Panomics Inc |
組織スライドからの核酸定量
|
EP2455404B1
(en)
|
2006-08-22 |
2016-02-10 |
Novo Nordisk A/S |
Anti-C5AR antibodies with improved properties
|
EP2061900A2
(en)
|
2006-08-25 |
2009-05-27 |
Oncotherapy Science, Inc. |
Prognostic markers and therapeutic targets for lung cancer
|
EP2064319B1
(en)
|
2006-08-28 |
2017-02-22 |
Yeda Research and Development Co. Ltd. |
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns
|
JP2008111824A
(ja)
*
|
2006-09-01 |
2008-05-15 |
Nox Technologies Inc |
腫瘍特異的tNOXアイソフォーム及び方法
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
US7985542B2
(en)
*
|
2006-09-07 |
2011-07-26 |
Institut Pasteur |
Genomic morse code
|
US9012162B2
(en)
*
|
2006-09-08 |
2015-04-21 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
|
US8055034B2
(en)
*
|
2006-09-13 |
2011-11-08 |
Fluidigm Corporation |
Methods and systems for image processing of microfluidic devices
|
US8050516B2
(en)
*
|
2006-09-13 |
2011-11-01 |
Fluidigm Corporation |
Methods and systems for determining a baseline during image processing
|
WO2008041183A2
(en)
|
2006-10-05 |
2008-04-10 |
Technion Research & Development Foundation Ltd. |
Microtubes and methods of producing same
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
DK2074230T3
(da)
|
2006-10-11 |
2013-02-25 |
Janssen Pharmaceutica Nv |
Sammensætninger og fremgangsmåder til behandling og diagnosticering af colon irritabile
|
EP1912067A1
(en)
*
|
2006-10-12 |
2008-04-16 |
Eppendorf Array Technologies S.A. |
Method for quantification of a target compound obtained from a biological sample upon chips
|
EP2076591A2
(en)
|
2006-10-20 |
2009-07-08 |
Danisco US, INC., Genencor Division |
Polyol oxidases
|
WO2008051762A2
(en)
*
|
2006-10-26 |
2008-05-02 |
Abbott Laboratories |
Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
|
US20080305512A1
(en)
*
|
2006-10-26 |
2008-12-11 |
Mattingly Phillip G |
Assay for cardiac troponin autoantibodies
|
US7776605B2
(en)
*
|
2006-10-26 |
2010-08-17 |
Abbott Laboratories |
Assay for cardiac troponin autoantibodies
|
WO2008049930A2
(en)
|
2006-10-27 |
2008-05-02 |
Janssen Pharmaceutica Nv |
A method for profiling kinase inhibitors
|
JP2010508815A
(ja)
|
2006-11-02 |
2010-03-25 |
イエール・ユニバーシテイ |
卵母細胞受容能の評価
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
WO2008067552A2
(en)
*
|
2006-11-30 |
2008-06-05 |
Fluidigm Corporation |
Method and apparatus for biological sample analysis
|
EP2102239B1
(en)
|
2006-11-30 |
2012-04-25 |
Research Development Foundation |
Improved immunoglobulin libraries
|
WO2008076321A1
(en)
|
2006-12-14 |
2008-06-26 |
Schering Corporation |
Engineered anti-tslp antibody
|
WO2008075364A2
(en)
*
|
2006-12-20 |
2008-06-26 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
US8506499B2
(en)
*
|
2007-01-04 |
2013-08-13 |
Musc Foundation For Research Development |
Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
|
DK2121977T3
(en)
*
|
2007-01-11 |
2017-09-18 |
Erasmus Univ Medical Center |
Capture (4C) OF CHROMOSOMES WITH CIRCULAR CONFORMATION
|
WO2008089103A2
(en)
|
2007-01-12 |
2008-07-24 |
University Of Maryland, Baltimore |
Targeting ncca-atp channel for organ protection following ischemic episode
|
CA2675967A1
(en)
*
|
2007-01-16 |
2008-07-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M |
Nucleic acid constructs and methods for specific silencing of h19
|
BRPI0720801A2
(pt)
|
2007-01-25 |
2014-09-16 |
Dupont Nutrition Biosci Aps |
Produção de um lipídio aciltranfersase a partir de células transformadas de bacillus licheniformis.
|
EP2450702A3
(en)
|
2007-01-26 |
2012-07-25 |
University Of Louisville Research Foundation, Inc. |
Methods of detecting autoantibodies for diagnosing and characterizing disorders
|
WO2008092094A2
(en)
*
|
2007-01-26 |
2008-07-31 |
University Of South Florida |
Method and materials for detection, diagnosis and management of ovarian cancer
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
US8911996B2
(en)
|
2007-01-31 |
2014-12-16 |
Technion Research & Development Foundation Limited |
Electrospun scaffolds and methods of generating and using same
|
EP2478924A1
(en)
|
2007-02-01 |
2012-07-25 |
Technion Research & Development Foundation |
Albumin fibers and fabrics and methods of generating and using same
|
MX2009008104A
(es)
|
2007-02-02 |
2009-08-07 |
Amgen Inc |
Hepcidina, antagonistas de hepcidina y metodos de uso.
|
US20080220498A1
(en)
*
|
2007-03-06 |
2008-09-11 |
Cervin Marguerite A |
Variant Buttiauxella sp. phytases having altered properties
|
US8143046B2
(en)
*
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
KR100855299B1
(ko)
*
|
2007-02-16 |
2008-08-29 |
건국대학교 산학협력단 |
인간 il-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 il-32측정법
|
JP2008203195A
(ja)
*
|
2007-02-22 |
2008-09-04 |
Japan Science & Technology Agency |
Bshの免疫測定用キットおよびbshの測定方法
|
SG178804A1
(en)
|
2007-02-23 |
2012-03-29 |
Schering Corp |
Engineered anti-il-23p19 antibodies
|
EP2059534B1
(en)
|
2007-02-23 |
2012-04-25 |
Schering Corporation |
Engineered anti-il-23p19 antibodies
|
WO2008106149A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Children's Medical Center Corporation |
Methods for predicting the onset of menarche
|
WO2008104979A2
(en)
|
2007-02-28 |
2008-09-04 |
Yeda Research And Development Co. Ltd. |
Nuclear targeting sequences
|
NZ579251A
(en)
|
2007-02-28 |
2012-06-29 |
Schering Corp |
Engineered anti-il-23r antibodies
|
EP2136843A1
(en)
|
2007-03-12 |
2009-12-30 |
Miraculins Inc. |
Biomarkers of prostate cancer and uses thereof
|
WO2008116150A2
(en)
|
2007-03-21 |
2008-09-25 |
Cedars-Sinai Medical Center |
Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease
|
EP2144935A2
(en)
|
2007-03-29 |
2010-01-20 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
JP5167338B2
(ja)
|
2007-03-30 |
2013-03-21 |
エンジーンアイシー モレキュラー デリバリー ピーティーワイ リミテッド |
哺乳動物細胞へのinvivo送達のための、プラスミド非含有機能性核酸を含有するインタクトな細菌由来ミニセル
|
CN101702920B
(zh)
|
2007-04-02 |
2013-03-13 |
特拉维夫大学拉莫特有限公司 |
癌细胞的检测方法及其在诊断和监测疾病治疗中的应用
|
EP2132333B1
(en)
|
2007-04-06 |
2011-11-23 |
Becton, Dickinson and Company |
Compositions and methods for the identification of a carbapenemase gene
|
MX341624B
(es)
|
2007-04-09 |
2016-08-26 |
Evogene Ltd |
Polinucleotidos, polipeptidos y metodos para aumentar el contenido de aceite, la velocidad de crecimiento y biomasa de las plantas.
|
EP2137535B1
(en)
*
|
2007-04-13 |
2015-06-03 |
Dana-Farber Cancer Institute, Inc. |
Receptor tyrosine kinase profiling
|
CA2683559C
(en)
|
2007-04-13 |
2019-09-24 |
Dana Farber Cancer Institute, Inc. |
Methods for treating cancer resistant to erbb therapeutics
|
US8003314B2
(en)
|
2007-04-16 |
2011-08-23 |
Diagnostic Hybrids, Inc. |
Methods for direct fluorescent antibody virus detection in liquids
|
WO2014064687A1
(en)
|
2012-10-22 |
2014-05-01 |
Deliversir Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2008129548A2
(en)
*
|
2007-04-23 |
2008-10-30 |
Segev Laboratories Limited |
A system for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US8338113B2
(en)
|
2007-05-01 |
2012-12-25 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods for detecting fetal cells in the maternal blood
|
DK2155789T3
(da)
|
2007-05-01 |
2013-10-21 |
Res Dev Foundation |
Immunoglobulin-Fc-biblioteker
|
WO2009009215A2
(en)
*
|
2007-05-02 |
2009-01-15 |
Emory University |
Enhancement of glycoprotein incorporation into virus-like particles
|
AU2008246368A1
(en)
|
2007-05-03 |
2008-11-13 |
Agency For Science, Technology And Research |
Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide
|
JP2010525833A
(ja)
|
2007-05-07 |
2010-07-29 |
プロタリクス リミテッド |
大規模な使い捨て型バイオリアクター
|
US20090081639A1
(en)
*
|
2007-05-31 |
2009-03-26 |
Phil Hill |
Assay for sensitivity to chemotherapeutic agents
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
US9102754B2
(en)
*
|
2007-06-28 |
2015-08-11 |
University Of Saskatchewan |
Immunomodulatory compositions and methods for treating disease with modified host defense peptides
|
WO2009009662A1
(en)
*
|
2007-07-10 |
2009-01-15 |
University Of South Florida |
Method of predicting non-response to first line chemotherapy
|
ATE540115T1
(de)
|
2007-07-11 |
2012-01-15 |
Yeda Res & Dev |
Nukleinsäurekonstruktsysteme mit fähigkeit zur diagnose oder behandlung eines zellzustands
|
KR101790908B1
(ko)
*
|
2007-07-12 |
2017-10-26 |
케모센트릭스, 인크. |
염증의 치료를 위한 ccr2 조절물질로서 융합된 헤테로아릴 피리딜과 페닐 벤젠술폰아마이드
|
AU2008277257B2
(en)
|
2007-07-15 |
2014-03-06 |
Hillman, Yitzchak Mr |
Disease treatment via antimicrobial peptides or their inhibitors
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
EP2910638B1
(en)
|
2007-07-24 |
2018-05-30 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
|
WO2009014726A1
(en)
|
2007-07-26 |
2009-01-29 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
US8679485B2
(en)
|
2007-08-02 |
2014-03-25 |
Gilead Biologics, Inc. |
Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
|
US8715743B2
(en)
|
2007-08-03 |
2014-05-06 |
Musc Foundation For Research Development |
Human monoclonal antibodies and methods for producing the same
|
CA2694832A1
(en)
|
2007-08-06 |
2009-02-12 |
Orion Genomics Llc |
Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene
|
US20120028880A1
(en)
|
2007-08-08 |
2012-02-02 |
Renata Pasqualini |
Vegfr-1/nrp-1 targeting peptides
|
US8067164B2
(en)
*
|
2007-08-12 |
2011-11-29 |
Integrated Dna Technologies, Inc. |
Microarray system with improved sequence specificity
|
WO2009023733A1
(en)
*
|
2007-08-13 |
2009-02-19 |
Trustees Of Tufts College |
Methods and microarrays for detecting enteric viruses
|
BRPI0814479A2
(pt)
|
2007-08-15 |
2016-07-12 |
Yeda Res & Dev |
"método para regular uma atividade de metaloproteinase 9 (mm9), método para identificar um agente capaz de regular especificamente a mmp-9, método de tratar a afecção clínica mediada pela mmp-9, molécula capaz de regular especificamente uma atividade da mmp-9, anticorpo humanizado e composição farmacêutica"
|
US20090068669A1
(en)
*
|
2007-09-12 |
2009-03-12 |
Elias Georges |
Slc9a3r1 directed diagnostics for neoplastic disease
|
CN101855549A
(zh)
|
2007-09-12 |
2010-10-06 |
耶达研究及发展有限公司 |
在免疫豁免部位内治疗肿瘤的方法
|
KR20140107677A
(ko)
|
2007-09-19 |
2014-09-04 |
플루리스템 리미티드 |
지방 또는 태반 조직 유래의 부착 세포 및 이의 치료 용도
|
US8114681B2
(en)
|
2007-10-05 |
2012-02-14 |
Affymetrix, Inc. |
Highly multiplexed particle-based assays
|
CA2702655A1
(en)
|
2007-10-19 |
2009-04-23 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
|
EP2599790A1
(en)
|
2007-11-26 |
2013-06-05 |
Yissum Research Development Company of The Hebrew University of Jerusalem |
Compositions comprising fibrous polypeptides and polysachharides
|
CA2709517C
(en)
|
2007-12-27 |
2019-02-26 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides useful for modifying water use efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
EP2238251B1
(en)
|
2007-12-27 |
2015-02-11 |
Protiva Biotherapeutics Inc. |
Silencing of polo-like kinase expression using interfering rna
|
JP5677703B2
(ja)
|
2008-01-10 |
2015-02-25 |
リサーチ ディベロップメント ファウンデーション |
Ehrlichiachaffeensisにのためのワクチンおよび診断
|
JP5701064B2
(ja)
|
2008-01-25 |
2015-04-15 |
アムジエン・インコーポレーテツド |
フェロポーチン抗体およびその使用方法
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
AU2009208607B2
(en)
*
|
2008-01-31 |
2013-08-01 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
CN101939019B
(zh)
|
2008-02-07 |
2014-07-16 |
康奈尔大学 |
用于预防或治疗胰岛素抵抗性的方法
|
JP2011515073A
(ja)
|
2008-02-20 |
2011-05-19 |
ジーツー インフラメイション プロプライエタリー リミテッド |
ヒト化抗C5aR抗体
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
EP2281079B1
(en)
|
2008-02-21 |
2015-04-01 |
Technion Research & Development Foundation Ltd. |
Microtubes and their applications
|
EP2363407A1
(en)
|
2008-02-28 |
2011-09-07 |
Murdoch University |
Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
|
US20090311695A1
(en)
*
|
2008-03-12 |
2009-12-17 |
Talat Nasim |
Method
|
AU2009227986C1
(en)
|
2008-03-27 |
2014-06-19 |
Murdoch University |
Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
|
CN102016039B
(zh)
*
|
2008-03-28 |
2017-06-09 |
Mdna生命科学有限公司 |
异常线粒体dna、相关的融合转录物及其杂交探针
|
EP2107125A1
(en)
|
2008-03-31 |
2009-10-07 |
Eppendorf Array Technologies SA (EAT) |
Real-time PCR of targets on a micro-array
|
EP2297200A1
(en)
*
|
2008-04-09 |
2011-03-23 |
Technion Research & Development Foundation Ltd. |
Anti influenza antibodies and uses thereof
|
WO2009125394A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anti human immunodeficiency antibodies and uses thereof
|
EP2636513B1
(en)
*
|
2008-04-10 |
2014-08-27 |
Stratasys Ltd. |
System and method for three dimensional model printing
|
PL2279254T3
(pl)
|
2008-04-15 |
2017-11-30 |
Protiva Biotherapeutics Inc. |
Nowe preparaty lipidowe do dostarczania kwasów nukleinowych
|
CA2721380A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Silencing of csn5 gene expression using interfering rna
|
GB0807161D0
(en)
*
|
2008-04-18 |
2008-05-21 |
Danisco |
Process
|
CN104491845A
(zh)
|
2008-04-18 |
2015-04-08 |
科尔普兰特有限公司 |
产生和使用原胶原的方法
|
CN102089433B
(zh)
|
2008-04-21 |
2014-08-13 |
丹齐格创新有限公司 |
植物病毒表达载体及其用于在植物基因组中产生遗传型变异的用途
|
KR20110011635A
(ko)
*
|
2008-04-23 |
2011-02-08 |
루미넥스 코포레이션 |
생물학적 기원의 출발 물질에서 발견된 복수의 분석물에 대한 기준의 생성 방법
|
EP2281062B1
(en)
|
2008-04-24 |
2017-11-29 |
The Trustees of Columbia University in the City of New York |
Geometric patterns and lipid bilayers for dna molecule organization
|
EP2279248B1
(en)
|
2008-04-30 |
2015-04-01 |
DuPont Nutrition Biosciences ApS |
Proteins
|
ES2487846T3
(es)
|
2008-05-01 |
2014-08-25 |
Amgen, Inc. |
Anticuerpos anti-hepcindina y métodos de uso
|
JP2010043063A
(ja)
|
2008-05-09 |
2010-02-25 |
Agency For Science Technology & Research |
川崎病の診断及び治療
|
US8847008B2
(en)
|
2008-05-22 |
2014-09-30 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility
|
AU2008356840B2
(en)
*
|
2008-05-22 |
2013-05-16 |
Centre National De La Recherche Scientifique (Cnrs) |
New optically pure compounds for improved therapeutic efficiency
|
EP2641606A1
(en)
|
2008-05-27 |
2013-09-25 |
Pluristem Ltd. |
Methods of treating inflammatory colon diseases
|
DK2620493T3
(da)
|
2008-05-28 |
2019-07-01 |
Univ Ramot |
Mesenkymale stamceller til behandling af CNS-sygdomme
|
WO2009152102A2
(en)
*
|
2008-06-10 |
2009-12-17 |
The Regents Of The University Of California |
Pro-fluorescent probes
|
EP2326419B1
(en)
|
2008-06-29 |
2021-04-07 |
Realbio Technologies Ltd. |
Liquid transfer device particularly useful as a capturing device in a biological assay process
|
CN102176914B
(zh)
|
2008-08-08 |
2014-12-17 |
新加坡科技研究局 |
用于诊断和治疗癌症的vhz
|
WO2010017544A2
(en)
|
2008-08-08 |
2010-02-11 |
Genisphere, Inc. |
Long-acting dna dendrimers and methods thereof
|
BR122021014172B1
(pt)
|
2008-08-18 |
2022-09-06 |
Evogene Ltd |
Método para aumentar a eficiência de uso do nitrogênio, eficiência de uso de fertilizantes, produção, taxa de crescimento, vigor, biomassa e/ou tolerância ao estresse de falta de nitrogênio de uma planta
|
CA2735790C
(en)
|
2008-09-02 |
2017-02-28 |
Pluristem Ltd. |
Adherent cells from placenta tissue and use thereof in therapy
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
EP2326340A4
(en)
|
2008-09-11 |
2013-01-23 |
Univ Ben Gurion |
COMPOSITIONS AND METHODS FOR TREATING PNEUMOCOCCAL INFECTIONS
|
RU2535966C2
(ru)
|
2008-09-12 |
2014-12-20 |
Криопрашис Криобиоложия Лтда. |
Клеточная терапия ишемической ткани
|
WO2010035107A2
(en)
|
2008-09-24 |
2010-04-01 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
US9434985B2
(en)
|
2008-09-25 |
2016-09-06 |
University Of Massachusetts |
Methods of identifying interactions between genomic loci
|
WO2010035261A2
(en)
|
2008-09-29 |
2010-04-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
US9207242B2
(en)
|
2008-10-09 |
2015-12-08 |
The University Of Hong Kong |
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
|
CA2736350C
(en)
*
|
2008-10-30 |
2021-06-22 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
CN102272157B
(zh)
|
2008-11-07 |
2015-11-25 |
研究发展基金会 |
用于抑制cripto/grp78复合物形成和信号的组合物和方法
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
WO2010064247A1
(en)
|
2008-12-03 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
EP2370092A1
(en)
|
2008-12-03 |
2011-10-05 |
Research Development Foundation |
Modulation of olfml-3 mediated angiogenesis
|
CN102281890B
(zh)
|
2008-12-05 |
2014-08-20 |
阿布拉西斯生物科学有限责任公司 |
Sparc结合肽及其应用
|
EP2633854B1
(en)
|
2008-12-05 |
2015-09-16 |
Yeda Research And Development Co. Ltd. |
miRNA-9 or miRNA-9* for use in treating ALS
|
WO2010066252A1
(en)
|
2008-12-09 |
2010-06-17 |
Dako Denmark A/S |
Method for evaluating pre-treatment
|
WO2010068757A1
(en)
|
2008-12-12 |
2010-06-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods useful for detecting and treating diseases associated with 16p chromosomal disruptions
|
WO2010071610A1
(en)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Severe chikungunya biomarkers
|
US9580752B2
(en)
|
2008-12-24 |
2017-02-28 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
|
US8552147B2
(en)
|
2008-12-29 |
2013-10-08 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
CA2744827C
(en)
|
2008-12-29 |
2019-10-15 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
|
EP2376653A2
(en)
|
2008-12-29 |
2011-10-19 |
Yissum Research Development Company of The Hebrew University of Jerusalem |
Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
EP2391377A2
(en)
|
2009-02-02 |
2011-12-07 |
Ramot at Tel-Aviv University Ltd. |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
EP2396429B1
(en)
|
2009-02-11 |
2015-05-27 |
Orion Genomics, LLC |
Combinations of polymorphisms for determining allele-specific expression of igf2
|
US20120165340A1
(en)
|
2009-02-11 |
2012-06-28 |
Ludwing Institute For Cancer Research Ltd. |
Pten phosphorylation-driven resistance to cancer treatment and altered patient prognosis
|
JP2012517238A
(ja)
|
2009-02-11 |
2012-08-02 |
カリス エムピーアイ インコーポレイテッド |
腫瘍の分子プロファイリング法
|
WO2010096658A1
(en)
|
2009-02-19 |
2010-08-26 |
The Cleveland Clinic Foundation |
Corin as a marker for heart failure
|
EP2401362B1
(en)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolated populations of renal stem cells and methods of isolating and using same
|
CA3123543A1
(en)
|
2009-03-02 |
2010-09-10 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
US8546330B2
(en)
|
2009-03-09 |
2013-10-01 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for treatment of neurodegenerative diseases
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
US20100240065A1
(en)
*
|
2009-03-18 |
2010-09-23 |
Boehringer Ingelheim International Gmbh |
Prolyl Hydroxylase Compositions and Methods of Use Thereof
|
US8481698B2
(en)
*
|
2009-03-19 |
2013-07-09 |
The President And Fellows Of Harvard College |
Parallel proximity ligation event analysis
|
CA2756760A1
(en)
*
|
2009-03-27 |
2010-11-04 |
Gojo Industries, Inc. |
Compositions and methods for screening and using compounds antagonizing spore-surface interactions
|
RU2011137486A
(ru)
|
2009-03-27 |
2013-05-10 |
Митомикс Инк. |
Аберрантная митохондриальная днк, ассоциированные с ней слитые транскрипты, продукты трансляции и гибрадизационные зонды
|
EP2414542B1
(en)
|
2009-03-30 |
2017-08-30 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Methods of predicting clinical course and treating multiple sclerosis
|
AU2010231514A1
(en)
|
2009-04-01 |
2011-11-03 |
Rappaport Family Institute For Research In The Medical Sciences |
A method of regulating proliferation and differentiation of keratinocytes
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
WO2010121294A1
(en)
|
2009-04-21 |
2010-10-28 |
Genetic Technologies Limited |
Methods for obtaining fetal genetic material
|
GB0908770D0
(en)
|
2009-04-24 |
2009-07-01 |
Danisco |
Method
|
SI2424896T1
(sl)
|
2009-04-30 |
2015-12-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Protitelesa anti-ceacam1 in postopki za njihovo uporabo
|
CA2760569C
(en)
|
2009-05-01 |
2018-01-02 |
Dako Denmark A/S |
New antibody cocktail
|
EP2430451B1
(en)
*
|
2009-05-14 |
2014-08-13 |
The Chancellors, Masters and Scholars of the University of Oxford |
Clinical diagnosis of hepatic fibrosis / cirrhosis using low abundant human plasma protein biomarkers
|
US20120058222A1
(en)
|
2009-05-19 |
2012-03-08 |
Danisco A/S |
Use
|
US9182403B2
(en)
|
2009-05-19 |
2015-11-10 |
Zetiq Technologies Ltd. |
Kits for and methods of differential staining of cervical cancer cells and/or tissues
|
WO2011019423A2
(en)
|
2009-05-20 |
2011-02-17 |
Schering Corporation |
Modulation of pilr receptors to treat microbial infections
|
WO2010137021A2
(en)
|
2009-05-27 |
2010-12-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
CN102639146A
(zh)
|
2009-05-27 |
2012-08-15 |
耶达研究及发展有限公司 |
蛋白酶体抑制剂及其用途
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
KR20120122869A
(ko)
|
2009-06-02 |
2012-11-07 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
신경변성 질환을 갖는 대상에서 항체에 의해 인식되는 소분자의 확인법
|
CA3095630A1
(en)
|
2009-06-10 |
2010-12-16 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
US20120129183A1
(en)
|
2009-06-24 |
2012-05-24 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
|
EP2446027A1
(en)
|
2009-06-25 |
2012-05-02 |
Danisco A/S |
Protein
|
US8569025B2
(en)
|
2009-06-29 |
2013-10-29 |
The University Of British Columbia |
Terpene synthases from santalum
|
EP2449114B9
(en)
|
2009-07-01 |
2017-04-19 |
Protiva Biotherapeutics Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
EP3636759B1
(en)
|
2009-07-17 |
2023-10-11 |
BioAtla, Inc. |
Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts
|
US8716464B2
(en)
|
2009-07-20 |
2014-05-06 |
Thomas W. Geisbert |
Compositions and methods for silencing Ebola virus gene expression
|
WO2011010309A1
(en)
|
2009-07-21 |
2011-01-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
A method of diagnosing cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
WO2011021194A2
(en)
|
2009-08-17 |
2011-02-24 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
MX2012002189A
(es)
|
2009-08-21 |
2012-03-16 |
Beeologics Inc |
Prevencion y cura de las enfermedades de los insectos beneficiosos a traves de moleculas.
|
CN102712683B
(zh)
|
2009-08-21 |
2014-09-10 |
吉联亚生物科技有限公司 |
赖氨酰氧化酶和loxl2的催化结构域
|
CN106619515A
(zh)
|
2009-08-27 |
2017-05-10 |
工业研究与发展基金会有限公司 |
脂质体组合物及其用途
|
ES2788869T3
(es)
|
2009-09-03 |
2020-10-23 |
Merck Sharp & Dohme |
Anticuerpos anti-GITR
|
WO2011030332A2
(en)
|
2009-09-08 |
2011-03-17 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
EP2475784A1
(en)
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
US20120171213A1
(en)
|
2009-09-10 |
2012-07-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
DK2477652T3
(en)
|
2009-09-16 |
2015-07-20 |
Vaxart Inc |
Immunization strategy for the prevention of infection H1Ni
|
WO2011033506A2
(en)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2011033511A1
(en)
|
2009-09-17 |
2011-03-24 |
Ramot At Tel-Aviv University Ltd. |
Peptides for the treatment of oxidative stress related disorders
|
CA2775092A1
(en)
|
2009-09-23 |
2011-03-31 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing genes expressed in cancer
|
WO2011038403A1
(en)
|
2009-09-28 |
2011-03-31 |
Yuling Luo |
Methods of detecting nucleic acid sequences with high specificity
|
US20110076232A1
(en)
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
WO2011040973A2
(en)
|
2009-10-02 |
2011-04-07 |
Ludwig Institute For Cancer Research Ltd. |
Tnf-immunoconjugates with fibroblast activation protein antibodies and methods and uses thereof
|
CA2776037A1
(en)
|
2009-10-02 |
2011-04-07 |
Ludwig Institute For Cancer Research Ltd |
Anti-fibroblast activation protein antibodies and methods and uses thereof
|
EP2486049A1
(en)
|
2009-10-06 |
2012-08-15 |
The Board Of Trustees Of The UniversityOf Illinois |
Human single-chain t cell receptors
|
CA2776756A1
(en)
|
2009-10-11 |
2011-04-14 |
Biogen Idec Ma Inc. |
Anti-vla-4 related assays
|
EP2488646B1
(en)
|
2009-10-14 |
2017-12-06 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Compositions for controlling varroa mites in bees
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
US9109206B2
(en)
|
2009-10-16 |
2015-08-18 |
Rutgers, The State University Of New Jersey |
Method for treating chronic nerve tissue injury using a cell therapy strategy
|
WO2011048600A1
(en)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
EP2494077A4
(en)
|
2009-10-27 |
2013-08-21 |
Caris Mpi Inc |
MOLECULAR PROFILING FOR PERSONALIZED MEDICINE
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
WO2011058557A1
(en)
|
2009-11-12 |
2011-05-19 |
Ramot At Tel-Aviv University Ltd. |
Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
|
CA3080762A1
(en)
|
2009-11-12 |
2011-05-19 |
Technion Research & Development Foundation Limited |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
WO2011062997A2
(en)
|
2009-11-17 |
2011-05-26 |
Musc Foundation For Research Development |
Human monoclonal antibodies to human nucleolin
|
US20120230974A1
(en)
|
2009-11-17 |
2012-09-13 |
Protalix Ltd |
Alkaline alpha galactosidase for the treatment of fabry disease
|
US8592151B2
(en)
*
|
2009-11-17 |
2013-11-26 |
Musc Foundation For Research Development |
Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
|
GB0920089D0
(en)
|
2009-11-17 |
2009-12-30 |
Danisco |
Method
|
US9733242B2
(en)
|
2012-10-07 |
2017-08-15 |
Sevident, Inc. |
Devices for capturing analyte
|
US9910040B2
(en)
|
2012-07-09 |
2018-03-06 |
Sevident, Inc. |
Molecular nets comprising capture agents and linking agents
|
US20120273993A1
(en)
|
2009-11-24 |
2012-11-01 |
Collplant Ltd. |
Method of generating collagen fibers
|
EP2806023B1
(en)
|
2009-11-30 |
2015-09-23 |
Pluristem Ltd. |
Adherent cells from placenta and use of same in disease treatment
|
US8652788B2
(en)
*
|
2009-12-02 |
2014-02-18 |
Abbott Laboratories |
Assay for diagnosis of cardiac myocyte damage
|
US8835120B2
(en)
*
|
2009-12-02 |
2014-09-16 |
Abbott Laboratories |
Assay for cardiac troponin-T (cTnT)
|
US8183002B2
(en)
*
|
2009-12-03 |
2012-05-22 |
Abbott Laboratories |
Autoantibody enhanced immunoassays and kits
|
US20110136141A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
WO2011067745A2
(en)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions and methods for enhancing plants resistance to abiotic stress
|
EP2862929B1
(en)
|
2009-12-09 |
2017-09-06 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for treating diseases, disorders or injury of the CNS
|
US8691227B2
(en)
|
2009-12-17 |
2014-04-08 |
Merck Sharp & Dohme Corp. |
Methods of treating multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease using agonists antibodies to PILR-α
|
GB0922377D0
(en)
|
2009-12-22 |
2010-02-03 |
Arab Gulf University The |
Mutant LDL receptor
|
AR081095A1
(es)
|
2009-12-28 |
2012-06-13 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados y metodos para utilizarlos para aumentar el rendimiento de la planta, biomasa, tasa de crecimiento, vigor, contenido de aceite, tolerancia al estres abiotico y eficacia en el uso de nitrogeno
|
EP3785712A1
(en)
|
2009-12-29 |
2021-03-03 |
Gamida-Cell Ltd. |
Methods for enhancing natural killer cell proliferation and activity
|
WO2011084882A2
(en)
|
2010-01-05 |
2011-07-14 |
Contrafect Corporation |
Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
|
SG182367A1
(en)
|
2010-01-05 |
2012-08-30 |
Vascular Biogenics Ltd |
Methods for use of a specific anti-angiogenic adenoviral agent
|
DK3339865T5
(da)
|
2010-01-11 |
2023-03-20 |
Biogen Ma Inc |
Assay for jc-virus-antistoffer
|
US11287423B2
(en)
|
2010-01-11 |
2022-03-29 |
Biogen Ma Inc. |
Assay for JC virus antibodies
|
US20130052165A1
(en)
|
2010-01-12 |
2013-02-28 |
Livnat Bangio |
Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby
|
AU2011210362B2
(en)
|
2010-01-27 |
2015-09-10 |
Yeda Research And Development Co. Ltd. |
Antibodies that inhibit metalloproteins
|
ES2719502T3
(es)
|
2010-01-29 |
2019-07-10 |
Advanced Cell Diagnostics Inc |
Métodos de detección in situ de ácidos nucleicos
|
US8574832B2
(en)
*
|
2010-02-03 |
2013-11-05 |
Massachusetts Institute Of Technology |
Methods for preparing sequencing libraries
|
SG183174A1
(en)
|
2010-02-04 |
2012-09-27 |
Gilead Biologics Inc |
Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
|
JP6046494B2
(ja)
|
2010-02-08 |
2016-12-14 |
アジェンシス,インコーポレイテッド |
161p2f10bタンパク質に結合する抗体薬物コンジュゲート(adc)
|
WO2011099006A2
(en)
|
2010-02-11 |
2011-08-18 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
AU2011219426A1
(en)
|
2010-02-24 |
2012-10-04 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
CA2790211C
(en)
|
2010-03-08 |
2020-06-09 |
Monsanto Technology Llc |
Methods and compositions for delivering polynucleotides into plants
|
US9267142B2
(en)
|
2010-03-08 |
2016-02-23 |
Yeda Research And Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
CN102918159A
(zh)
|
2010-03-11 |
2013-02-06 |
雅各布·埃德尔 |
产生氢的方法
|
WO2011114251A1
(en)
|
2010-03-18 |
2011-09-22 |
Danisco A/S |
Foodstuff
|
WO2011125015A2
(en)
|
2010-04-05 |
2011-10-13 |
Bar-Ilan University |
Protease-activatable pore-forming polypeptides
|
SG184466A1
(en)
|
2010-04-06 |
2012-11-29 |
Massachusetts Inst Technology |
Gene-expression profiling with reduced numbers of transcript measurements
|
US9125931B2
(en)
|
2010-04-06 |
2015-09-08 |
Massachusetts Institute Of Technology |
Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
|
US9458438B2
(en)
|
2010-04-12 |
2016-10-04 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
WO2011129382A1
(en)
|
2010-04-16 |
2011-10-20 |
Abbott Japan Co. Ltd. |
Methods and reagents for diagnosing rheumatoid arthritis
|
RU2012148398A
(ru)
|
2010-04-18 |
2014-05-27 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
МОЛЕКУЛЫ И СПОСОБЫ ПРИМЕНЕНИЯ МОЛЕКУЛ ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНЕЙ, АССОЦИИРОВАННЫХ С ErbB/ErbB ЛИГАНДАМИ
|
BR112012027504B1
(pt)
|
2010-04-28 |
2022-05-24 |
Evogene Ltd |
Método de aumento de produção, biomassa, taxa de crescimento, e/ou tolerância ao estresse abiótico de uma planta, e, construção de ácidos nucleicos
|
WO2011138778A2
(en)
|
2010-05-04 |
2011-11-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
WO2011138785A2
(en)
|
2010-05-05 |
2011-11-10 |
Rappaport Family Institute For Research In The Medical Sciences |
Use of ccl1 in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
CA2798441A1
(en)
|
2010-05-07 |
2011-11-10 |
Abbvie Inc. |
Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
|
US20120190563A1
(en)
|
2010-05-07 |
2012-07-26 |
Abbott Laboratories |
Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
|
US20130059325A1
(en)
|
2010-05-13 |
2013-03-07 |
Tel HaShomer Medical Research Infratructure and Services Ltd. |
Isolated populations of adult renal cells and methods of isolating and using same
|
EP2572197A4
(en)
|
2010-05-18 |
2013-08-28 |
Texas A & M Univ Sys |
METHOD AND COMPOSITION FOR DIAGNOSING AND MONITORING INFLAMMATORY DISEASES
|
EP2808344A1
(en)
|
2010-06-01 |
2014-12-03 |
Monash University |
Antibodies directed to the receptor tyrosine kinase c-Met
|
EP2575859B1
(en)
|
2010-06-03 |
2018-09-19 |
Ramot at Tel Aviv University, Ltd. |
Methods of treating diabetes and compositions capable of same
|
CA2801849A1
(en)
|
2010-06-07 |
2011-12-15 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia
|
WO2011158242A2
(en)
|
2010-06-16 |
2011-12-22 |
Futuragene Israel Ltd. |
Pest -resistant plants containing a combination of a spider toxin and a chitinase
|
WO2011158243A2
(en)
|
2010-06-16 |
2011-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
US20130316338A1
(en)
|
2010-06-29 |
2013-11-28 |
The United States Government As Represented By The Department Of Veterans Affairs |
CCR6 As A Biomarker of Alzheimer's Disease
|
GB201011513D0
(en)
|
2010-07-08 |
2010-08-25 |
Danisco |
Method
|
US9512188B2
(en)
|
2010-07-12 |
2016-12-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Isolated polynucleotides and methods and plants using same for regulating plant acidity
|
EP2407242A1
(en)
|
2010-07-13 |
2012-01-18 |
Dublin City University |
Direct clone analysis and selection technology
|
BR112013000984A2
(pt)
|
2010-07-15 |
2017-10-03 |
Technion Res & Dev Foundation |
Estrutura de ácido nucleico para o aumento da tolerância ao estresse abiótico em plantas
|
US20130189284A1
(en)
|
2010-07-15 |
2013-07-25 |
Technion Research & Development Foundation Ltd. |
Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
JP2013538555A
(ja)
|
2010-07-15 |
2013-10-17 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
Mhcクラスiiとグルタミン酸デカルボキシラーゼ(gad)自己抗原性ペプチドとの天然型複合体に対するt細胞受容体様特異性を有する単離された高親和性実体
|
EP2593230A2
(en)
|
2010-07-16 |
2013-05-22 |
Vanderbilt University |
Low resource processor using surface tension valves for extracting, concentrating and detecting molecular species
|
SG10201902596TA
(en)
|
2010-07-16 |
2019-04-29 |
Bioatla Llc |
Novel methods of protein evolution
|
US9624469B2
(en)
|
2010-07-22 |
2017-04-18 |
Cellect Biotherapeutics Ltd. |
Regulatory immune cells with enhanced targeted cell death effect
|
JP5813111B2
(ja)
|
2010-07-23 |
2015-11-17 |
ルミネックス コーポレーション |
イムノアッセイにおける試薬の反応性を制御するためのコカップリング
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
WO2012014208A2
(en)
|
2010-07-27 |
2012-02-02 |
Yeda Research And Development Co. Ltd. |
Methods and systems for assessing clonality of cell cultures
|
JP2013535966A
(ja)
|
2010-07-27 |
2013-09-19 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
引き抜かれた毛包由来のケラチン生成細胞から誘導多能性幹細胞を生成させる方法
|
EP2600885A2
(en)
|
2010-08-04 |
2013-06-12 |
Ramot at Tel Aviv University, Ltd. |
Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
|
US8956859B1
(en)
|
2010-08-13 |
2015-02-17 |
Aviex Technologies Llc |
Compositions and methods for determining successful immunization by one or more vaccines
|
SG187830A1
(en)
|
2010-08-22 |
2013-03-28 |
Univ Ramot |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
MX2018009863A
(es)
|
2010-08-30 |
2022-06-14 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para aumentar la eficacia en el uso de nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico.
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
JP6283223B2
(ja)
|
2010-09-07 |
2018-02-21 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
多能性幹細胞を培養するための新規な方法および培養培地
|
EP2613799A1
(en)
|
2010-09-07 |
2013-07-17 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
BR112013005756A2
(pt)
|
2010-09-08 |
2018-12-26 |
Yeda Research And Development Co. Ltd |
use of anti third party central memory t cells for anti-leukemia/lymphoma treatment
|
JP2013540731A
(ja)
|
2010-09-08 |
2013-11-07 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
安定かつ長期間の生着のための免疫抑制薬物組合せ
|
EP2616539A1
(en)
|
2010-09-15 |
2013-07-24 |
Ramot at Tel-Aviv University Ltd. |
Methods of expanding and redifferentiating islet beta cells
|
WO2012038956A1
(en)
|
2010-09-20 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
US20120071343A1
(en)
|
2010-09-20 |
2012-03-22 |
Advanced Cell Diagnostics, Inc |
Biomarkers for differentiating melanoma from benign nevus in the skin
|
KR102504750B1
(ko)
|
2010-09-29 |
2023-03-02 |
어젠시스 인코포레이티드 |
191p4d12 단백질에 결합하는 항체 약물 컨쥬게이트(adc)
|
BR112013008037A2
(pt)
|
2010-10-04 |
2019-09-24 |
Centre Nat Rech Scient |
compostos multivalentes como tratamento antibiótico
|
EP2441520A1
(en)
|
2010-10-12 |
2012-04-18 |
Eppendorf AG |
Real-time amplification and micro-array based detection of nucleic acid targets in a flow chip assay
|
WO2012052872A2
(en)
|
2010-10-17 |
2012-04-26 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for the treatment of insulin-associated medical conditions
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
ES2648564T3
(es)
|
2010-10-21 |
2018-01-04 |
Advanced Cell Diagnostics, Inc. |
Método ultrasensible para la detección in situ de ácidos nucleicos
|
US20130216603A1
(en)
|
2010-10-27 |
2013-08-22 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
ES2688457T3
(es)
|
2010-10-28 |
2018-11-02 |
Yeda Research And Development Co. Ltd. |
Métodos de generación de anticuerpos contra metaloenzimas
|
WO2012059922A2
(en)
|
2010-11-03 |
2012-05-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Transgenic plants with improved saccharification yields and methods of generating same
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
MX2013005413A
(es)
|
2010-11-15 |
2014-02-27 |
Univ Ramot |
Analogos de dipeptidos para el tratamiento de afecciones asociadas con la formacion de fibrillas amiloides.
|
US10117895B2
(en)
|
2010-11-17 |
2018-11-06 |
Ben-Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
US9574171B2
(en)
|
2010-12-02 |
2017-02-21 |
Technion Research & Development Foundation Ltd. |
Methods of generating corneal cells and cell populations comprising same
|
EP2463382A1
(en)
|
2010-12-07 |
2012-06-13 |
Enterologics, Inc. |
Method for identifying E. Coli M-17
|
US9404087B2
(en)
|
2010-12-15 |
2016-08-02 |
Kadimastem Ltd. |
Insulin producing cells derived from pluripotent stem cells
|
BR122021002251B1
(pt)
|
2010-12-22 |
2021-09-14 |
Evogene Ltd |
Método para aumentar a tolerância ao estresse abiótico, rendimento, biomassa, taxa de crescimento, vigor, conteúdo de óleo, rendimento de fibras, qualidade de fibras e/ou eficiência de utilização de nitrogênio de uma planta, e, construção de ácido nucleico isolado
|
AR084358A1
(es)
|
2010-12-27 |
2013-05-08 |
Lilly Co Eli |
Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
|
US10226499B2
(en)
|
2010-12-28 |
2019-03-12 |
Kamedis Ltd. |
Plant extracts for the treatment and prevention of infections
|
AU2011352207B2
(en)
|
2010-12-31 |
2016-03-03 |
Bioatla, Llc |
Comprehensive monoclonal antibody generation
|
ES2632768T3
(es)
|
2011-01-17 |
2017-09-15 |
Life Technologies Corporation |
Flujo de trabajo para la detección de ligandos empleando ácidos nucleicos
|
EP2665814B1
(en)
|
2011-01-20 |
2017-05-17 |
Protalix Ltd. |
Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
|
ES2638640T3
(es)
|
2011-01-28 |
2017-10-23 |
Advanced Cell Diagnostics, Inc. |
Ensayo de HPV RNAscope® para determinar el estado del HPV en los cánceres de cabeza y cuello y en lesiones cervicales
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
JP5804395B2
(ja)
|
2011-02-03 |
2015-11-04 |
ポップ テスト オンコロジー エルエルシー |
診断と治療のためのシステムおよび方法
|
WO2012109133A1
(en)
|
2011-02-07 |
2012-08-16 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
EP2678042B1
(en)
|
2011-02-23 |
2018-05-09 |
The Board of Trustees of the University of Illionis |
Amphiphilic dendron-coils, micelles thereof and uses
|
UA113843C2
(xx)
|
2011-03-02 |
2017-03-27 |
|
Стійка до бактерій трансгенна рослина, яка містить дисфункціональні білки t3ss
|
US9365828B2
(en)
|
2011-03-03 |
2016-06-14 |
Ramot At Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
CN103597073B
(zh)
|
2011-03-06 |
2019-06-07 |
默克雪兰诺有限公司 |
低岩藻糖细胞系及其应用
|
WO2012120377A2
(en)
|
2011-03-08 |
2012-09-13 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
US9061006B2
(en)
|
2011-03-08 |
2015-06-23 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (PKU)
|
WO2012125582A1
(en)
|
2011-03-11 |
2012-09-20 |
Board Of Regents Of The University Of Nebraska |
Biomarker for coronary artery disease
|
EP2686348B1
(en)
|
2011-03-17 |
2015-12-30 |
Ramot at Tel-Aviv University Ltd. |
Bi- and monospecific, asymmetric antibodies and methods of generating the same
|
EP2685976B1
(en)
|
2011-03-17 |
2017-12-27 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
WO2012127320A1
(en)
|
2011-03-22 |
2012-09-27 |
Pluristem Ltd. |
Methods for treating radiation or chemical injury
|
JP2014511677A
(ja)
|
2011-03-22 |
2014-05-19 |
コーネル・ユニバーシティー |
鑑別困難な良性甲状腺病変と悪性甲状腺病変との識別法
|
KR20140036164A
(ko)
|
2011-03-24 |
2014-03-25 |
뉴림 파머슈티칼스 (1991) 리미티드 |
신경보호 펩타이드
|
EP2691538A1
(en)
|
2011-03-28 |
2014-02-05 |
Novartis AG |
Markers associated with cyclin-dependent kinase inhibitors
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
ES2661466T3
(es)
|
2011-04-01 |
2018-04-02 |
Immunogen, Inc. |
Métodos para aumentar la eficacia de la terapia contra el cáncer con FOLR1
|
WO2012138941A1
(en)
|
2011-04-05 |
2012-10-11 |
Longevity Biotech, Inc. |
Compositions comprising glucagon analogs and methods of making and using the same
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
BR112013025782B1
(pt)
|
2011-04-06 |
2022-09-06 |
Ramot At Tel-Aviv University Ltd |
Método de medição de uma atividade metabólica (am) de uma célula, método ex-vivo de diagnóstico de uma doença associada a uma atividade metabólica modificada em um indivíduo em necessidade respectiva, método ex-vivo de otimização do tratamento de uma doença, método ex- vivo de monitoramento do tratamento de uma doença em um indivíduo e método ex-vivo de identificação de um agente capaz de alterar uma atividade metabólica das células
|
BR112013025811A2
(pt)
|
2011-04-08 |
2016-11-29 |
Danisco Us Inc |
"composição e método para remover uma mancha de base lipídica de uma superfície"
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
ES2768296T3
(es)
|
2011-04-15 |
2020-06-22 |
Pluristem Ltd |
Métodos y sistemas para recoger células
|
WO2012145630A2
(en)
|
2011-04-21 |
2012-10-26 |
The Rockefeller University |
Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
|
BR122020018201B1
(pt)
|
2011-05-03 |
2021-11-09 |
Evogene Ltd |
Métodos para aumentar o rendimento, biomassa, taxa de crescimento, vigor, conteúdo de óleo, rendimento de fibra, qualidade da fibra, tolerância ao estresse abiótico e/ou eficiência no uso de nitrogênio de uma planta, para gerar uma planta transgênica, e, construto de ácido nucléico
|
EP2704793B1
(en)
|
2011-05-04 |
2019-07-17 |
Ramot at Tel Aviv University, Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
JP2014515476A
(ja)
|
2011-05-20 |
2014-06-30 |
アボットジャパン株式会社 |
非特異的結合を減少させるためのイムノアッセイ方法及び試薬
|
US9506051B2
(en)
|
2011-05-20 |
2016-11-29 |
Oligomerix, Inc. |
Tau protease compositions and methods of use
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
EP2715350B1
(en)
|
2011-05-23 |
2017-09-27 |
Yeda Research and Development Co. Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
EP3527581A3
(en)
|
2011-05-31 |
2019-11-27 |
Hutchison Biofilm Medical Solutions Limited |
Dispersion and detachment of cell aggregates
|
RS58967B1
(sr)
|
2011-05-31 |
2019-08-30 |
Biogen Ma Inc |
Metod evaluacije rizika za pml
|
WO2012164565A1
(en)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
ES2693647T3
(es)
|
2011-06-06 |
2018-12-13 |
Novo Nordisk A/S |
Anticuerpos terapéuticos
|
US9415103B2
(en)
|
2011-06-14 |
2016-08-16 |
Yeda Research And Development Co. Ltd. |
Combination therapy to prevent DCIS formation and progression to breast cancer
|
WO2012176203A1
(en)
|
2011-06-23 |
2012-12-27 |
Kaiima Bio Agritech Ltd. |
Common wheat, plants or parts thereof having partially or fully multiplied genome, hybrids and products thereof and methods of generating and using same
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
US9835621B2
(en)
|
2011-07-14 |
2017-12-05 |
University Of Kentucky Research Foundation |
Process for detection of alzheimer's disease from a serum sample
|
EP2734843A2
(en)
|
2011-07-18 |
2014-05-28 |
President and Fellows of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
CA2841722A1
(en)
|
2011-07-20 |
2013-01-24 |
Kaiima Bio Agritech Ltd. |
Maize plants having a partially or fully multiplied genome and uses thereof
|
EP2550982A1
(en)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Devices for surgical applications
|
EP2739736B1
(en)
|
2011-08-04 |
2017-04-19 |
Yeda Research and Development Co. Ltd. |
Mir-135 and compositions comprising same for the treatment of serotonin associated medical conditions
|
CA2842971C
(en)
|
2011-08-05 |
2019-11-12 |
Research Development Foundation |
Improved methods and compositions for modulation of olfml3 mediated angiogenesis
|
WO2013021389A2
(en)
|
2011-08-09 |
2013-02-14 |
Yeda Research And Development Co.Ltd. |
Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
|
AR087524A1
(es)
|
2011-08-14 |
2014-03-26 |
Kaiima Bio Agritech Ltd |
Plantas de trigo durum que tienen un genoma parcial completamente multiplicado y sus usos
|
AU2012296576B2
(en)
|
2011-08-15 |
2017-09-07 |
The University Of Chicago |
Compositions and methods related to antibodies to staphylococcal protein a
|
EP3348575A1
(en)
|
2011-08-16 |
2018-07-18 |
Emory University |
Jaml specific binding agents, antibodies, and uses related thereto
|
WO2013035070A1
(en)
|
2011-09-07 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Olfactory signature and odorant mixture having the same
|
EP2753716B1
(en)
|
2011-09-08 |
2017-11-01 |
Yeda Research and Development Co. Ltd. |
Novel risk biomarkers for lung cancer
|
SG11201400513PA
(en)
|
2011-09-08 |
2014-06-27 |
Yeda Res & Dev |
Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
|
EP2755467B1
(en)
|
2011-09-13 |
2017-07-19 |
Monsanto Technology LLC |
Methods and compositions for weed control
|
US9840715B1
(en)
|
2011-09-13 |
2017-12-12 |
Monsanto Technology Llc |
Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
|
MX343071B
(es)
|
2011-09-13 |
2016-10-21 |
Monsanto Technology Llc |
Metodos y composiciones para el control de malezas.
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
BR112014005975A8
(pt)
|
2011-09-13 |
2017-09-12 |
Monsanto Technology Llc |
Método de controle de planta, método de redução de expressão de um gene pds em uma planta, cassete de expressão microbiana, método de fazer um polinucleotídeo, método de identificação de polinucleotídeos, e composições para controle de erva daninha
|
MX343072B
(es)
|
2011-09-13 |
2016-10-21 |
Monsanto Technology Llc |
Metodos y composiciones para controlar malezas.
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US9920326B1
(en)
|
2011-09-14 |
2018-03-20 |
Monsanto Technology Llc |
Methods and compositions for increasing invertase activity in plants
|
US9249467B2
(en)
|
2011-09-16 |
2016-02-02 |
Steven Goodison |
Bladder cancer detection composition, kit and associated methods
|
ES2826393T3
(es)
|
2011-10-05 |
2021-05-18 |
Univ Rockefeller |
Lisinas de bacteriófago diméricas
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
BR112014009536A2
(pt)
|
2011-10-21 |
2017-04-18 |
Augurex Life Sciences Corp |
antígenos derivados de 14-3-3 xitrulinada e usos dos mesmos no diagnóstico de artrite reumatoide
|
US9145559B2
(en)
|
2011-10-27 |
2015-09-29 |
Yeda Research And Development Co. Ltd. |
Methods of treating cancer
|
WO2013064163A1
(en)
|
2011-11-01 |
2013-05-10 |
Academisch Medisch Centrum |
Methylation markers for colorectal cancer
|
SG11201401648RA
(en)
|
2011-11-03 |
2014-05-29 |
Quark Pharmaceuticals Inc |
Methods and compositions for neuroprotection
|
US20140323549A1
(en)
|
2011-11-08 |
2014-10-30 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
WO2013076729A1
(en)
|
2011-11-23 |
2013-05-30 |
Danziger Dan Flower Farm |
Otomeria plants
|
WO2013076730A1
(en)
|
2011-11-27 |
2013-05-30 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis and compositions capable of same
|
JP2015500279A
(ja)
|
2011-12-08 |
2015-01-05 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
哺乳動物胎児肺細胞および該細胞の治療的使用
|
EP2795295B1
(en)
|
2011-12-12 |
2017-10-11 |
Step Ahead Innovations, Inc. |
Water-quality monitoring system
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
SG11201403456UA
(en)
|
2011-12-22 |
2014-07-30 |
Yeda Res & Dev |
A combination therapy for a stable and long term engraftment using specific protocols for t/b cell depletion
|
CN105833925B
(zh)
|
2011-12-22 |
2018-11-13 |
瑞尔比奥技术有限公司 |
用于分析物测定的序贯侧向流动毛细管装置
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
WO2013098820A1
(en)
|
2011-12-28 |
2013-07-04 |
Kaiima Bio Agritech Ltd. |
Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
|
JP2015505245A
(ja)
|
2011-12-29 |
2015-02-19 |
ベイラー リサーチ インスティテュートBaylor Research Institute |
川崎病のためのバイオマーカー
|
SG11201403756PA
(en)
|
2012-01-01 |
2014-11-27 |
Qbi Entpr Ltd |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
EP2807271B1
(en)
|
2012-01-24 |
2018-08-22 |
CD Diagnostics, Inc. |
System for detecting infection in synovial fluid
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
WO2013114374A1
(en)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
US10184131B2
(en)
|
2012-02-06 |
2019-01-22 |
A.B. Seeds Ltd. |
Isolated polynucleotides expressing or modulating microRNAs or targets of same, transgenic plants comprising same and uses thereof
|
SG11201404608WA
(en)
|
2012-02-13 |
2014-09-26 |
Gamida Cell Ltd |
Mesenchymal stem cells conditioned medium and methods of generating and using the same
|
PL3326642T3
(pl)
|
2012-02-14 |
2021-06-14 |
Opko Biologics Ltd. |
Długo działające czynniki krzepnięcia i ich zastosowania
|
WO2013121405A1
(en)
|
2012-02-19 |
2013-08-22 |
Protalix Ltd. |
Oral unit dosage forms and uses of same for the treatment of gaucher disease
|
EP3401393B1
(en)
|
2012-02-22 |
2020-02-19 |
Exostem Biotec Ltd |
Micrornas for the generation of astrocytes
|
EP2844745A2
(en)
|
2012-02-22 |
2015-03-11 |
Brainstem Biotec Ltd. |
Generation of neural stem cells and motor neurons
|
BR112014020824B1
(pt)
|
2012-02-24 |
2022-10-04 |
Protiva Biotherapeutics Inc |
Lipídeo, partícula de lipídeo e composição farmacêutica
|
PT3263564T
(pt)
|
2012-02-29 |
2020-09-10 |
Chemocentryx Inc |
Aza-aril 1h-pirazol-1-il benzeno sulfonamidas como antagonistas de ccr(9)
|
US20150101074A1
(en)
|
2012-03-01 |
2015-04-09 |
The State of Israel, Ministry of Agriculture & Rural Development, Agriculture Research |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
ES2691931T3
(es)
|
2012-03-07 |
2018-11-29 |
Yeda Research And Development Co. Ltd. |
Composiciones para inhibición de quiescina sulfhidrilo oxidasa (QSOX1) y usos de las mismas
|
WO2013142299A1
(en)
|
2012-03-20 |
2013-09-26 |
Biogen Idec Ma Inc. |
Jcv neutralizing antibodies
|
US9334308B2
(en)
|
2012-03-22 |
2016-05-10 |
Ramot At Tel-Aviv University Ltd. |
PLIF multimeric peptides and uses thereof
|
WO2013149219A2
(en)
|
2012-03-30 |
2013-10-03 |
Sorrento Therapeutics Inc. |
Fully human antibodies that bind to vegfr2
|
US20140178869A1
(en)
|
2012-04-05 |
2014-06-26 |
Advanced Cell Diagnostics, Inc. |
Detection of immunoglobulin light chain restriction by rna in situ hybridization
|
US9925143B2
(en)
|
2012-04-18 |
2018-03-27 |
Ramot At Tel-Aviv University Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
PE20142405A1
(es)
|
2012-04-19 |
2015-01-25 |
Opko Biolog Ltd |
Variantes de oxintomodulina de accion prolongada y metodos de produccion de las mismas
|
US20130280696A1
(en)
|
2012-04-23 |
2013-10-24 |
Elliott Millenson |
Devices and methods for detecting analyte in bodily fluid
|
WO2013160895A1
(en)
|
2012-04-24 |
2013-10-31 |
Biokine Therapeutics Ltd. |
Peptides and use thereof in the treatment of large cell lung cancer
|
CA2910320A1
(en)
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
|
JP6181158B2
(ja)
|
2012-05-09 |
2017-08-16 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
TNF−α阻害剤としてのTACEプロドメインの変異体およびその医学的使用
|
US9969813B2
(en)
|
2012-05-10 |
2018-05-15 |
Bioatla, Llc |
Multi-specific monoclonal antibodies
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
AU2013264742B2
(en)
|
2012-05-24 |
2018-10-04 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
SG11201408330XA
(en)
|
2012-05-24 |
2015-01-29 |
Mountgate Group Ltd |
Compositions and methods related to prevention and treatment of rabies infection
|
CN115093480A
(zh)
|
2012-05-31 |
2022-09-23 |
索伦托药业有限公司 |
与pd-l1结合的抗原结合蛋白
|
EP2854910B1
(en)
|
2012-06-01 |
2020-04-15 |
Icahn School of Medicine at Mount Sinai |
Ceramide levels in the treatment and prevention of infections
|
US9731048B2
(en)
|
2012-06-03 |
2017-08-15 |
Ben-Gurion University Of The Negev Research And Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
CN104684576B
(zh)
|
2012-06-04 |
2019-08-06 |
奥普科生物制品有限公司 |
聚乙二醇化的oxm变体
|
JP6429771B2
(ja)
|
2012-06-21 |
2018-11-28 |
ソレント・セラピューティクス・インコーポレイテッドSorrento Therapeutics, Inc. |
c−Metに結合する抗原結合タンパク質
|
CA2875710C
(en)
|
2012-06-22 |
2021-06-29 |
John Wayne Cancer Institute |
Molecular malignancy in melanocytic lesions
|
JP6438391B2
(ja)
|
2012-06-22 |
2018-12-12 |
ソレント・セラピューティクス・インコーポレイテッドSorrento Therapeutics, Inc. |
Ccr2に結合する抗原結合タンパク質
|
EP2870110A1
(en)
|
2012-07-03 |
2015-05-13 |
Nanospun Technologies Ltd. |
Methods and devices for adsorption and biodegradation of petroleum
|
EP3309263B1
(en)
|
2012-07-09 |
2019-12-25 |
Novartis AG |
Biomarkers associated with cdk inhibitors
|
US9725698B2
(en)
|
2012-07-11 |
2017-08-08 |
Imstem Biotechnology, Inc. |
Trophoblast-derived mesenchymal stem cells (T-MSCs) produced from human embryonic stem cells, methods and uses thereof
|
US20150173883A1
(en)
|
2012-07-18 |
2015-06-25 |
President And Fellows Of Harvard College |
Modification of surfaces for simultaneous repellency and targeted binding of desired moieties
|
WO2014018375A1
(en)
|
2012-07-23 |
2014-01-30 |
Xenon Pharmaceuticals Inc. |
Cyp8b1 and uses thereof in therapeutic and diagnostic methods
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
EP2877489A4
(en)
|
2012-07-27 |
2016-04-13 |
Univ Illinois |
MANIPULATION OF T-CELL RECEPTORS
|
DK2880155T3
(da)
|
2012-07-29 |
2019-07-15 |
Yeda Res & Dev |
Anvendelse af den reduktive glycinvej til generering af formatotrofiske og autotrofiske mikroorganismer
|
EP2880447B1
(en)
|
2012-07-31 |
2019-05-15 |
Novartis AG |
Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2)
|
WO2014020608A1
(en)
|
2012-07-31 |
2014-02-06 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing and treating motor neuron diseases
|
DK2880151T3
(da)
|
2012-08-06 |
2020-08-17 |
Brainstorm Cell Therapeutics Ltd |
Fremgangsmåder til frembringelse af mesenkymale stemceller, som udskiller neurotrofiske faktorer
|
SG11201501286PA
(en)
|
2012-08-23 |
2015-05-28 |
Agensys Inc |
Antibody drug conjugates (adc) that bind to 158p1d7 proteins
|
AR092868A1
(es)
|
2012-09-03 |
2015-05-06 |
A B Seeds Ltd |
Metodo para mejorar la tolerancia al estres abiotico de plantas y plantas generadas mediante dicho metodo
|
EP2895197B1
(en)
|
2012-09-12 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
CA2886120A1
(en)
|
2012-10-08 |
2014-04-17 |
St. Jude Children's Research Hospital |
Therapies based on control of regulatory t cell stability and function via a neuropilin-1:semaphorin axis
|
US11105809B2
(en)
|
2012-10-09 |
2021-08-31 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
EP4356927A2
(en)
|
2012-10-12 |
2024-04-24 |
Arizona Board of Regents on behalf of Arizona State University |
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
|
CN104870647A
(zh)
|
2012-10-18 |
2015-08-26 |
孟山都技术公司 |
用于植物害虫控制的方法和组合物
|
WO2014063097A1
(en)
|
2012-10-19 |
2014-04-24 |
Danisco Us Inc. |
Stabilization of biomimetic membranes
|
US20150354006A1
(en)
|
2012-10-19 |
2015-12-10 |
Novartis Ag |
Markers for acute lymphoblastic leukemia
|
US9395369B2
(en)
|
2012-10-19 |
2016-07-19 |
Regents Of The University Of Minnesota |
Guinea pig cytomegalovirus (CIDMTR strain)
|
DK2912064T3
(da)
|
2012-10-24 |
2019-07-22 |
Res Found Dev |
Jam-c-antistoffer og fremgangsmåder til behandling af cancer
|
WO2014064682A1
(en)
|
2012-10-24 |
2014-05-01 |
Yeda Research And Development Co. Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
US9926564B2
(en)
|
2012-10-29 |
2018-03-27 |
Yeda Research And Development Co. Ltd. |
Aptamers, multimeric aptamers and uses thereof
|
US9808534B2
(en)
|
2012-11-20 |
2017-11-07 |
Opko Biologics Ltd. |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
EP2925359A2
(en)
|
2012-11-29 |
2015-10-07 |
Yeda Research and Development Co., Ltd. |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
|
WO2015079413A2
(en)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
WO2014106837A2
(en)
|
2013-01-01 |
2014-07-10 |
A. B. Seeds Ltd. |
ISOLATED dsRNA MOLECULES AND METHODS OF USING SAME FOR SILENCING TARGET MOLECULES OF INTEREST
|
US10047399B2
(en)
|
2013-01-07 |
2018-08-14 |
The Cleveland Clinic Foundation |
ABCA1 downregulation in prostate cancer
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
US10047356B2
(en)
|
2013-01-17 |
2018-08-14 |
Novellusdx Ltd. |
Methods and systems for identifying patient specific driver mutations
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
US10000767B2
(en)
|
2013-01-28 |
2018-06-19 |
Monsanto Technology Llc |
Methods and compositions for plant pest control
|
US9411930B2
(en)
|
2013-02-01 |
2016-08-09 |
The Regents Of The University Of California |
Methods for genome assembly and haplotype phasing
|
EP3323884A1
(en)
|
2013-02-01 |
2018-05-23 |
The United States Of America as Represented by the Secretary, Department of Health an Human Service |
Method for generating retinal pigment epithelium (rpe) cells from induced pluripotent stem cells (ipscs)
|
CN108624668B
(zh)
|
2013-02-01 |
2022-12-02 |
加利福尼亚大学董事会 |
用于基因组组装及单体型定相的方法
|
EP2950808B1
(en)
|
2013-02-04 |
2019-08-21 |
Ramot at Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
WO2014130846A1
(en)
|
2013-02-22 |
2014-08-28 |
Seungpyo Hong |
Transdermal drug delivery using amphiphilic dendron-coil micelles
|
EP2964668B1
(en)
|
2013-03-06 |
2019-11-27 |
Protalix Ltd. |
Tnf alpha inhibitor polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
|
JP6622591B2
(ja)
|
2013-03-06 |
2019-12-18 |
プロタリクス リミテッド |
TNFαポリペプチド阻害薬を発現する植物細胞の、治療法における使用
|
TWI582239B
(zh)
|
2013-03-11 |
2017-05-11 |
諾華公司 |
與wnt抑制劑相關之標記
|
AR095233A1
(es)
|
2013-03-13 |
2015-09-30 |
Monsanto Technology Llc |
Métodos y composiciones para el control de malezas
|
CA2905027A1
(en)
|
2013-03-13 |
2014-10-09 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP2970479B1
(en)
|
2013-03-14 |
2019-04-24 |
Novartis AG |
Antibodies against notch 3
|
WO2014159242A1
(en)
|
2013-03-14 |
2014-10-02 |
Novartis Ag |
Notch 3 mutants and uses thereof
|
US9273349B2
(en)
|
2013-03-14 |
2016-03-01 |
Affymetrix, Inc. |
Detection of nucleic acids
|
WO2014153056A2
(en)
|
2013-03-14 |
2014-09-25 |
Parkash Gill |
Cancer treatment using antibodies that bing cell surface grp78
|
US20140283211A1
(en)
|
2013-03-14 |
2014-09-18 |
Monsanto Technology Llc |
Methods and Compositions for Plant Pest Control
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2014144170A1
(en)
|
2013-03-15 |
2014-09-18 |
The Cleveland Clinic Foundation |
In-vitro method for monoclonal antibody production using non-human act1 -deficient mice
|
EP3404116B1
(en)
|
2013-03-15 |
2022-10-19 |
The University of Chicago |
Methods and compositions related to t-cell activity
|
US9789164B2
(en)
|
2013-03-15 |
2017-10-17 |
Longevity Biotech, Inc. |
Peptides comprising non-natural amino acids and methods of making and using the same
|
ES2945994T3
(es)
|
2013-03-15 |
2023-07-11 |
Gladiator Biosciences Inc |
Dominios Gla como agentes de direccionamiento
|
EP2976097B1
(en)
|
2013-03-21 |
2021-05-26 |
CollPlant Ltd. |
Compositions comprising collagen and prp for tissue regeneration and their production method
|
US20160082071A1
(en)
|
2013-03-24 |
2016-03-24 |
Biokine Therapeutics Ltd. |
Methods of treating myeloid leukemia
|
EP4285988A3
(en)
|
2013-03-27 |
2024-03-06 |
Cedars-Sinai Medical Center |
Treating fibrosis by inhibiting tl1a
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
EP2988767A1
(en)
|
2013-04-21 |
2016-03-02 |
Yeda Research and Development Co., Ltd. |
Agents for downregulation of the activity and/or amount of bcl-xl and/or bcl-w
|
ES2831424T3
(es)
|
2013-04-23 |
2021-06-08 |
Yeda Res & Dev |
Células madre pluripotentes naif aisladas y métodos para generarlas
|
ES2671002T3
(es)
|
2013-04-25 |
2018-06-04 |
Yeda Research And Development Co., Ltd. |
Uso de péptidos inhibidores para el tratamiento de enfermedades inflamatorias
|
WO2014176047A1
(en)
|
2013-04-25 |
2014-10-30 |
Novartis Ag |
Markers for ezh2 inhibitors
|
EP2999717B1
(en)
|
2013-05-21 |
2018-08-08 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
CA2913155A1
(en)
|
2013-05-21 |
2014-11-27 |
President And Fellows Of Harvard College |
Engineered heme-binding compositions and uses thereof
|
RU2015151047A
(ru)
|
2013-05-27 |
2017-06-29 |
Ракуто Био Текнолоджис Лтд. |
Содержащие ферментную систему косметические композиции
|
EP3004334A4
(en)
|
2013-05-28 |
2016-12-21 |
Biogen Ma Inc |
METHODS OF EVALUATION RISK OF DEVELOPMENT OF PML
|
CA2915033C
(en)
|
2013-06-12 |
2023-08-29 |
The General Hospital Corporation |
Methods, kits, and systems for multiplexed detection of target molecules and uses thereof
|
WO2014204814A1
(en)
|
2013-06-18 |
2014-12-24 |
Dnatrix, Inc. |
Treatment of brain cancer with oncolytic adenovirus
|
WO2014205230A1
(en)
|
2013-06-19 |
2014-12-24 |
Step Ahead Innovations Inc. |
Aquatic environment water parameter testing systems and methods
|
EP3013380B1
(en)
|
2013-06-24 |
2022-11-23 |
Ramot at Tel-Aviv University Ltd. |
Omentum based scaffold and delivery system
|
US20160296609A1
(en)
|
2013-06-28 |
2016-10-13 |
Baylor Research Institute |
Dendritic cell asgpr targeting immunotherapeutics for multiple sclerosis
|
EP3030663B1
(en)
|
2013-07-19 |
2019-09-04 |
Monsanto Technology LLC |
Compositions and methods for controlling leptinotarsa
|
WO2015010108A1
(en)
|
2013-07-19 |
2015-01-22 |
Cedars-Sinai Medical Center |
Signature of tl1a (tnfsf15) signaling pathway
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
JP6510518B2
(ja)
|
2013-08-01 |
2019-05-08 |
アジェンシス,インコーポレイテッド |
Cd37タンパク質に結合する抗体薬物結合体(adc)
|
WO2015027120A1
(en)
|
2013-08-21 |
2015-02-26 |
Jiang Jean X |
Compositions and methods for targeting connexin hemichannels
|
EP3039030B1
(en)
|
2013-08-29 |
2018-09-19 |
Yeda Research and Development Co. Ltd. |
Selective inhibitors of alpha2 isoform of na,k-atpase and use for reduction of intra-ocular pressure
|
HUE055856T2
(hu)
|
2013-08-30 |
2021-12-28 |
Immunogen Inc |
Antitestek és vizsgálatok a folsavreceptor 1 kimutatására
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
EP3046929B1
(en)
|
2013-09-17 |
2019-01-16 |
Yeda Research and Development Co., Ltd. |
Erk-derived peptides and uses thereof
|
JP6474795B2
(ja)
|
2013-10-01 |
2019-02-27 |
カディマステム リミテッド |
薬物スクリーニング及び筋萎縮性側索硬化症(als)の処置における使用のための、ヒト多能性幹細胞からのアストロサイトの指向性分化
|
SG11201602540XA
(en)
|
2013-10-03 |
2016-04-28 |
Oklahoma Med Res Found |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
US9476884B2
(en)
|
2013-10-04 |
2016-10-25 |
University Of Massachusetts |
Hybridization- independent labeling of repetitive DNA sequence in human chromosomes
|
PL3060239T3
(pl)
|
2013-10-21 |
2020-11-02 |
Opko Biologics Ltd. |
Polipeptydy długo działające i sposoby ich wytwarzania i podawania
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
WO2015059690A1
(en)
|
2013-10-24 |
2015-04-30 |
Yeda Research And Development Co. Ltd. |
Polynucleotides encoding brex system polypeptides and methods of using s ame
|
US20160243187A1
(en)
|
2013-10-31 |
2016-08-25 |
Biokine Therapeutics Ltd. |
Methods of treating acute myeloid leukemia with a flt3 mutation
|
US9540642B2
(en)
|
2013-11-04 |
2017-01-10 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Compositions and methods for controlling arthropod parasite and pest infestations
|
US20170002064A1
(en)
|
2013-11-08 |
2017-01-05 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
US10172916B2
(en)
|
2013-11-15 |
2019-01-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of treating heart failure with agonists of hypocretin receptor 2
|
MX2016006584A
(es)
|
2013-11-20 |
2016-09-06 |
Univ Iowa Res Found |
Métodos y composiciones para tratar los depósitos de amiloide.
|
WO2015077615A1
(en)
|
2013-11-22 |
2015-05-28 |
The Board Of Trustees Of The University Of Illinois |
Engineered high-affinity human t cell receptors
|
CA2925698C
(en)
|
2013-11-28 |
2021-11-09 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Rna polymerase i inhibitors and uses thereof
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
ES2697757T3
(es)
|
2013-12-10 |
2019-01-28 |
Yeda Res & Dev |
Uso de enzimas que catalizan la síntesis de piruvato a partir de formiato y acetil-CoA y bacterias que expresan la misma
|
EP3546474B1
(en)
|
2013-12-18 |
2021-07-07 |
President and Fellows of Harvard College |
Crp capture/detection of gram positive bacteria
|
CA2934039A1
(en)
|
2013-12-19 |
2015-06-25 |
Danisco Us Inc. |
Use of hydrophobins to increase gas transferin aerobic fermentation processes
|
EP3447493B1
(en)
|
2014-01-07 |
2020-05-13 |
Bioatla, LLC |
Proteins targeting orthologs
|
JP7037884B2
(ja)
|
2014-01-13 |
2022-03-17 |
ベイラー リサーチ インスティテュート |
Hpv及びhpv関連疾患に対する新規のワクチン
|
AU2015206585A1
(en)
|
2014-01-15 |
2016-07-21 |
Monsanto Technology Llc |
Methods and compositions for weed control using EPSPS polynucleotides
|
KR102448454B1
(ko)
|
2014-01-29 |
2022-09-28 |
다나-파버 캔서 인스티튜트 인크. |
Muc1-c/세포외 도메인 (muc1-c/ecd)에 대한 항체
|
US20160340659A1
(en)
|
2014-01-30 |
2016-11-24 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
|
CN106470699A
(zh)
|
2014-02-03 |
2017-03-01 |
耶路撒冷希伯来大学的益生研究开发有限公司 |
使用酪蛋白激酶i抑制剂以消耗干细胞的用途
|
US10125365B2
(en)
|
2014-02-05 |
2018-11-13 |
Yeda Research And Development Co. Ltd. |
Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
EP3102607B1
(en)
|
2014-02-06 |
2018-08-22 |
Yeda Research and Development Co. Ltd. |
Anti cd84 antibodies, compositions comprising same and uses thereof
|
US20150247204A1
(en)
|
2014-02-07 |
2015-09-03 |
The General Hopital Corporation |
Differential diagnosis of hepatic neoplasms
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
US10564149B2
(en)
|
2014-02-11 |
2020-02-18 |
Brainstorm Cell Therapeutics Ltd. |
Populations of mesenchymal stem cells that secrete neurotrophic factors
|
WO2015123565A1
(en)
|
2014-02-14 |
2015-08-20 |
The General Hospital Corporation |
Methods for diagnosing igg4-related disease
|
US20150247205A1
(en)
|
2014-02-28 |
2015-09-03 |
The General Hospital Corporation |
Diagnosis of multiple myeloma and lymphoma
|
US20170067894A1
(en)
|
2014-03-03 |
2017-03-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method and device for detection of pseudomonas aeruginosa
|
EP2923709A1
(en)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Multi-component-multistage malaria vaccine
|
EP3420809A1
(en)
|
2014-04-01 |
2019-01-02 |
Monsanto Technology LLC |
Compositions and methods for controlling insect pests
|
EP3129075A4
(en)
|
2014-04-10 |
2017-12-06 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
WO2015159293A2
(en)
|
2014-04-14 |
2015-10-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A method and kit for determining the tissue or cell origin of dna
|
US10590467B2
(en)
|
2014-04-17 |
2020-03-17 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing DNA binding moieties attached to DNA
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
PL3137502T3
(pl)
|
2014-04-27 |
2021-03-08 |
Famewave Ltd. |
Humanizowane przeciwciała przeciwko CEACAM1
|
EP3058085B1
(en)
|
2014-04-28 |
2021-02-17 |
Yeda Research and Development Co., Ltd. |
Microbiome response to agents
|
BR112016025516A2
(pt)
|
2014-05-04 |
2018-01-16 |
Forrest Innovations Ltd |
composições para controle de mosquito e usos das mesmas
|
US10247729B2
(en)
|
2014-05-05 |
2019-04-02 |
Microbplex, Inc. |
Media elaborated with newly synthesized antibodies (MENSA) and uses thereof
|
RU2744836C2
(ru)
|
2014-05-08 |
2021-03-16 |
Новодиакс, Инк. |
Прямой иммуногистохимический анализ
|
WO2015179435A1
(en)
|
2014-05-19 |
2015-11-26 |
Bayer Healthcare Llc |
Optimized humanized monoclonal antibodies against activated protein c and uses thereof
|
WO2015177800A2
(en)
|
2014-05-22 |
2015-11-26 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
WO2015186129A1
(en)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
EP3149155B1
(en)
|
2014-06-02 |
2020-09-23 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
WO2015200223A1
(en)
|
2014-06-23 |
2015-12-30 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via rna interference
|
WO2015198320A1
(en)
|
2014-06-24 |
2015-12-30 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
SG11201610630RA
(en)
|
2014-06-25 |
2017-01-27 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Identification of cancer stem cell markers and use of same for diagnosis and treatment
|
EP3161138A4
(en)
|
2014-06-25 |
2017-12-06 |
Monsanto Technology LLC |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
WO2015198326A1
(en)
|
2014-06-26 |
2015-12-30 |
Ramot At Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
BR112017000710B1
(pt)
|
2014-07-15 |
2024-02-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Polipeptídeo isolado, composição de matéria, e, uso do polipeptídeo isolado ou da composição da matéria
|
US11015229B2
(en)
|
2014-07-21 |
2021-05-25 |
Novellusdx Ltd. |
Methods and systems for determining oncogenic index of patient specific mutations
|
CN106715719B
(zh)
|
2014-07-21 |
2022-08-02 |
福尔生物治疗有限公司 |
用于确定患者特定突变的药物反应的方法
|
WO2016018887A1
(en)
|
2014-07-29 |
2016-02-04 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
EP3194572B1
(en)
|
2014-07-30 |
2023-10-25 |
Yeda Research and Development Co. Ltd. |
Media for culturing pluripotent stem cells
|
AU2015296029B2
(en)
|
2014-08-01 |
2022-01-27 |
Dovetail Genomics, Llc |
Tagging nucleic acids for sequence assembly
|
EP3180621B1
(en)
|
2014-08-14 |
2020-04-01 |
Memed Diagnostics Ltd. |
Computational analysis of biological data using manifold and a hyperplane
|
WO2016028523A2
(en)
|
2014-08-22 |
2016-02-25 |
Sorrento Therapeutics, Inc. |
Antigen binding proteins that bind cxcr3
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
EP2992895A1
(en)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Three-component-multistage malaria vaccine
|
AU2015313811A1
(en)
|
2014-09-08 |
2017-04-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (TKI)
|
US10526416B2
(en)
|
2014-09-08 |
2020-01-07 |
Yeda Research And Development Co. Ltd. |
Anti-HER3 antibodies and uses of same
|
US20180010132A1
(en)
|
2014-09-11 |
2018-01-11 |
Novartis Ag |
Inhibition of prmt5 to treat mtap-deficiency-related diseases
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
PL3110447T3
(pl)
|
2014-09-16 |
2020-10-19 |
Synermore Biologics Co., Ltd. |
Przeciwciało anty-EGFR i jego zastosowania
|
WO2016042561A2
(en)
|
2014-09-21 |
2016-03-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Downregulating mir-132 for the treatment of lipid related disorders
|
SG11201702793XA
(en)
|
2014-10-06 |
2017-05-30 |
Chemocentryx Inc |
Combination therapy of inhibitors of c-c chemokine receptor type 9 (ccr9) and anti-alha4beta7 integrin blocking antibodies
|
EP3207156A1
(en)
|
2014-10-13 |
2017-08-23 |
Life Technologies Corporation |
Methods, kits & compositions for determining gene copy numbers
|
JP6767374B2
(ja)
|
2014-10-20 |
2020-10-14 |
ジェン−プローブ・インコーポレーテッド |
赤血球溶解溶液
|
DK3209773T3
(da)
|
2014-10-24 |
2020-06-15 |
Dupont Nutrition Biosci Aps |
Prolintolerante tripeptidylpeptidaser og anvendelser deraf
|
US20170306360A1
(en)
|
2014-10-24 |
2017-10-26 |
Danisco Us Inc. |
Method for producing alcohol by use of a tripeptidyl peptidase
|
CN107406825B
(zh)
|
2014-11-13 |
2022-04-08 |
恩祖迪克控股有限公司 |
甲壳纲十足目雌性动物的功能性别反转
|
US20190102512A1
(en)
|
2014-11-17 |
2019-04-04 |
Yeda Research And Development Co., Ltd. |
Method of analyzing microbiome
|
US20180042994A1
(en)
|
2014-11-17 |
2018-02-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
EP3221340A1
(en)
|
2014-11-19 |
2017-09-27 |
Koninklijke Philips N.V. |
Diagnostic method employing hnl
|
WO2016079739A2
(en)
|
2014-11-20 |
2016-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
|
EP3224353B9
(en)
|
2014-11-26 |
2023-08-09 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Targeted elimination of bacterial genes
|
CA2968808A1
(en)
|
2014-11-27 |
2016-06-02 |
Danziger Innovations Ltd. |
Nucleic acid constructs for genome editing
|
WO2016089920A1
(en)
|
2014-12-01 |
2016-06-09 |
The Broad Institute, Inc. |
Method for in situ determination of nucleic acid proximity
|
EP3227446A1
(en)
|
2014-12-01 |
2017-10-11 |
Novartis AG |
Compositions and methods for diagnosis and treatment of prostate cancer
|
EP4242329A3
(en)
|
2014-12-08 |
2023-10-25 |
Berg LLC |
Use of markers including filamin a in the diagnosis and treatment of prostate cancer
|
US10688330B2
(en)
|
2014-12-11 |
2020-06-23 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
KR20220151045A
(ko)
|
2014-12-23 |
2022-11-11 |
4디 파마 리서치 리미티드 |
면역 조정
|
HUE037476T2
(hu)
|
2014-12-23 |
2018-08-28 |
4D Pharma Res Ltd |
Pirin polipeptid és immunmodulálás
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
KR102514912B1
(ko)
|
2014-12-30 |
2023-03-27 |
셀 큐어 뉴로사이언시스 리미티드 |
망막 질환의 치료 방법
|
WO2016108240A1
(en)
|
2014-12-30 |
2016-07-07 |
Cell Cure Neurosciences Ltd. |
Assessing retinal pigment epithelial cell populations
|
DK3240892T5
(da)
|
2014-12-30 |
2020-10-19 |
Cell Cure Neurosciences Ltd |
Rpe-cellepopulationer og fremgangsmåder til dannelse deraf
|
IL253208B2
(en)
|
2015-01-04 |
2023-03-01 |
Protalix Ltd |
Converted DNase and its uses
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
US10968449B2
(en)
|
2015-01-22 |
2021-04-06 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
CA2976236A1
(en)
|
2015-02-09 |
2016-08-18 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides displaying improved complement activation
|
WO2016130986A1
(en)
|
2015-02-13 |
2016-08-18 |
Sorrento Therapeutics, Inc. |
Antibody therapeutics that bind ctla4
|
SG11201706730XA
(en)
|
2015-02-17 |
2017-09-28 |
Dovetail Genomics Llc |
Nucleic acid sequence assembly
|
WO2016138312A2
(en)
|
2015-02-25 |
2016-09-01 |
Vanderbilt University |
Antibody-mediated neutralization of marburg virus
|
WO2016135732A1
(en)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
WO2016145099A1
(en)
|
2015-03-09 |
2016-09-15 |
Agensys, Inc. |
Antibody drug conjugates (adc) that bind to flt3 proteins
|
WO2016142948A1
(en)
|
2015-03-11 |
2016-09-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
US11873483B2
(en)
|
2015-03-11 |
2024-01-16 |
The Broad Institute, Inc. |
Proteomic analysis with nucleic acid identifiers
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
GB2554572B
(en)
|
2015-03-26 |
2021-06-23 |
Dovetail Genomics Llc |
Physical linkage preservation in DNA storage
|
WO2016157175A1
(en)
|
2015-03-27 |
2016-10-06 |
Yeda Research And Development Co. Ltd. |
Methods of treating motor neuron diseases
|
JP2018518152A
(ja)
|
2015-03-27 |
2018-07-12 |
ユニバーシティ オブ サザン カリフォルニア |
充実性腫瘍を処置するためのlhrに指向されたcar t細胞治療
|
US9612534B2
(en)
|
2015-03-31 |
2017-04-04 |
Tokyo Electron Limited |
Exposure dose homogenization through rotation, translation, and variable processing conditions
|
JP2018511325A
(ja)
|
2015-03-31 |
2018-04-26 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
グルタミン酸オキサロ酢酸トランスアミナーゼ1(got1)、その調製物および製造方法およびその使用
|
WO2016157192A1
(en)
|
2015-04-01 |
2016-10-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
PL3280401T3
(pl)
|
2015-04-07 |
2022-02-14 |
Ela Pharma Ltd |
Kompozycje do leczenia i/lub zapobiegania martwicy komórek lub tkanek specjalnie ukierunkowane na katepsynę C i/lub CELA1 i/lub CELA3A i/lub strukturalnie związane z nimi enzymy
|
US10059774B2
(en)
|
2015-04-08 |
2018-08-28 |
Sorrento Therapeutics, Inc. |
Antibody therapeutics that bind CD38
|
EP3081575A1
(en)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium parasite antibodies
|
AU2016255725B2
(en)
|
2015-04-27 |
2021-09-23 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
ES2911341T3
(es)
|
2015-04-29 |
2022-05-18 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Composiciones antifitopatogénicas
|
US20190031759A1
(en)
|
2015-04-30 |
2019-01-31 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
US11845928B2
(en)
|
2015-05-04 |
2023-12-19 |
Tsinghua University |
Methods and kits for fragmenting DNA
|
CN106117288B
(zh)
|
2015-05-08 |
2019-10-15 |
生捷科技控股公司 |
二硫键连接的可逆终止子
|
EP3294280A1
(en)
|
2015-05-11 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
WO2016185471A1
(en)
|
2015-05-17 |
2016-11-24 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
EP3297680A2
(en)
|
2015-05-20 |
2018-03-28 |
Yeda Research and Development Co. Ltd |
Method of targeting senescent cells
|
JP2018515564A
(ja)
|
2015-05-21 |
2018-06-14 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
健康増進のための細菌群
|
WO2016193969A2
(en)
|
2015-05-29 |
2016-12-08 |
Opko Biologics Ltd. |
Pegylated oxyntomodulin variants
|
UY36703A
(es)
|
2015-06-02 |
2016-12-30 |
Monsanto Technology Llc |
Composiciones y métodos para la administración de un polinucleótido en una planta
|
EP3302030A4
(en)
|
2015-06-03 |
2019-04-24 |
Monsanto Technology LLC |
METHODS AND COMPOSITIONS FOR THE INTRODUCTION OF NUCLEIC ACIDS IN PLANTS
|
JP7010473B2
(ja)
|
2015-06-04 |
2022-02-10 |
ユニバーシティ オブ サザン カリフォルニア |
Lym-1およびlym-2標的化car細胞免疫療法
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
EA201890048A1
(ru)
|
2015-06-15 |
2018-06-29 |
4Д Фарма Рисёрч Лимитед |
Композиции, содержащие бактериальные штаммы
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
ME03511B
(me)
|
2015-06-15 |
2020-04-20 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
EA201890050A1
(ru)
|
2015-06-15 |
2018-06-29 |
4Д Фарма Рисёрч Лимитед |
Композиции, содержащие бактериальные штаммы
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
ES2917884T3
(es)
|
2015-06-18 |
2022-07-12 |
Yeda Res & Dev |
Protocolos de acondicionamiento y uso de los mismos para la regeneración de tejidos
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
KR102473014B1
(ko)
|
2015-06-19 |
2022-11-30 |
옵코 바이오로직스 리미티드 |
장기-작용성 응고 인자 및 그의 제조 방법
|
CN107849595A
(zh)
|
2015-06-26 |
2018-03-27 |
杜邦营养生物科学有限公司 |
用于蛋白水解产物的氨肽酶
|
GB2556004A
(en)
|
2015-07-10 |
2018-05-16 |
Univ West Virginia |
Markers of stroke and stroke severity
|
EP3322424B1
(en)
|
2015-07-16 |
2023-10-11 |
Yeda Research and Development Co., Ltd. |
Use of anti third party central memory t cells
|
WO2017009842A2
(en)
|
2015-07-16 |
2017-01-19 |
Biokine Therapeutics Ltd. |
Compositions and methods for treating cancer
|
WO2017013648A1
(en)
|
2015-07-19 |
2017-01-26 |
Yeda Research And Development Co. Ltd. |
SELECTIVE INHIBITORS OF Alpha2-CONTAINING ISOFORMS OF Na,K-ATPase AND USE THEREOF FOR REDUCTION OF INTRAOCULAR PRESSURE
|
WO2017015334A1
(en)
|
2015-07-21 |
2017-01-26 |
Saint Louis University |
Compositions and methods for diagnosing and treating endometriosis-related infertility
|
PE20181011A1
(es)
|
2015-07-22 |
2018-06-26 |
Phytopharma Int Ltd |
Composiciones ingeribles por abejas, procedimientos para el uso de las mismas para producir miel y miel producida de esta manera
|
ES2865024T3
(es)
|
2015-07-29 |
2021-10-14 |
Hadasit Med Res Service |
Producción a gran escala de células de epitelio pigmentario retiniano
|
WO2017021963A1
(en)
|
2015-08-03 |
2017-02-09 |
Biokine Therapeutics Ltd. |
Cxcr4 binding agents for treatment of diseases
|
CN108136051A
(zh)
|
2015-08-04 |
2018-06-08 |
Cd诊断股份有限公司 |
检测不良局部组织反应(altr)坏死的方法
|
WO2017021961A1
(en)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Methods of screening for riboswitches and attenuators
|
AU2016303631B2
(en)
|
2015-08-05 |
2022-07-28 |
Cell Cure Neurosciences Ltd. |
Preparation of photoreceptors for the treatment of retinal diseases
|
PL3331994T3
(pl)
|
2015-08-05 |
2023-01-30 |
Cell Cure Neurosciences Ltd. |
Wytwarzanie komórek nabłonka barwnikowego siatkówki
|
US10435457B2
(en)
|
2015-08-06 |
2019-10-08 |
President And Fellows Of Harvard College |
Microbe-binding molecules and uses thereof
|
EP3334449B1
(en)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using cd24
|
US20180237790A1
(en)
|
2015-08-13 |
2018-08-23 |
Forrest Innovation Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
AU2016308339A1
(en)
|
2015-08-18 |
2018-04-12 |
Baylor College Of Medicine |
Methods and compositions for altering function and structure of chromatin loops and/or domains
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
HUE056054T2
(hu)
|
2015-08-25 |
2022-02-28 |
Prothena Biosciences Ltd |
Eljárások foszforilezett alfa-szinuklein kimutatására
|
WO2017040380A2
(en)
|
2015-08-28 |
2017-03-09 |
Research Development Foundation |
Engineered antibody fc variants
|
EP3344756A4
(en)
|
2015-09-02 |
2019-09-04 |
University of Massachusetts |
DETECTION OF LOCI OF GENES COMPRISING MATRIX REPETITIONS OF CRISPR AND / OR POLYCHROMATIC MONO-GUIDE RIBONUCLEIC ACIDS
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
US11453864B2
(en)
|
2015-09-08 |
2022-09-27 |
University Of Massachusetts |
DNase H activity of Neisseria meningitidis Cas9
|
WO2017042816A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation of perforin positive dendritic cells in cancer treatment
|
US11001872B2
(en)
|
2015-09-22 |
2021-05-11 |
Shawn Clark |
Designing customized protein-specific buffer system
|
JP6836586B2
(ja)
|
2015-09-29 |
2021-03-03 |
エイチティージー モレキュラー ダイアグノスティクス, インコーポレイテッド |
びまん性大細胞型b細胞性リンパ腫(dlbcl)を亜型決定するための方法
|
SG11201802912PA
(en)
|
2015-10-10 |
2018-05-30 |
Intrexon Corp |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
ES2893100T3
(es)
|
2015-10-12 |
2022-02-08 |
Advanced Cell Diagnostics Inc |
Detección in situ de variantes de nucleótidos en muestras con un elevado nivel de ruido, y composiciones y métodos relacionados con ésta
|
AU2016341198B2
(en)
|
2015-10-19 |
2023-03-09 |
Dovetail Genomics, Llc |
Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection
|
EP3365376A1
(en)
|
2015-10-25 |
2018-08-29 |
Yeda Research and Development Co., Ltd. |
Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
|
CA3002919A1
(en)
|
2015-10-26 |
2017-05-04 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CA3187317A1
(en)
|
2015-10-27 |
2017-05-04 |
Jay Pharma, Inc. |
Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
EP3370791A1
(en)
|
2015-11-03 |
2018-09-12 |
Ariel-University Research and Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
US11814440B2
(en)
|
2015-11-09 |
2023-11-14 |
The Children's Hospital Of Philadelphia |
Glypican 2 as a cancer marker and therapeutic target
|
EP3374524A4
(en)
|
2015-11-11 |
2019-06-26 |
Ramot at Tel-Aviv University Ltd. |
PROCESS FOR DETECTION OF 5-HYDROXYMETHYLCYTOSINE AND FOR DIAGNOSIS OF CANCER
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
EP3209310B1
(en)
|
2015-11-20 |
2018-01-31 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
US11679133B2
(en)
|
2015-11-30 |
2023-06-20 |
Kadimastem Ltd. |
Methods for differentiating and purifying pancreatic endocrine cells
|
ES2861449T3
(es)
|
2015-12-02 |
2021-10-06 |
Stcube & Co Inc |
Anticuerpos y moléculas que se unen inmunoespecíficamente a BTN1A1 y los usos terapéuticos de los mismos
|
EP3176183A1
(en)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
|
KR20180100122A
(ko)
|
2015-12-02 |
2018-09-07 |
주식회사 에스티사이언스 |
당화된 btla(b- 및 t-림프구 약화인자)에 특이적인 항체
|
EP3383418B1
(en)
|
2015-12-04 |
2021-10-20 |
Board of Regents, The University of Texas System |
Slc45a2 peptides for immunotherapy
|
WO2017103930A1
(en)
|
2015-12-16 |
2017-06-22 |
Ramot At Tel-Aviv University Ltd. |
Particles comprising decellularized omentum
|
JOP20200228A1
(ar)
|
2015-12-21 |
2017-06-16 |
Novartis Ag |
تركيبات وطرق لخفض تعبير البروتين tau
|
EP3393524B1
(en)
|
2015-12-22 |
2022-04-06 |
The Regents of The University of Colorado, A Body Corporate |
Protecting rnas from degradation using engineered viral rnas
|
WO2017115367A1
(en)
|
2015-12-28 |
2017-07-06 |
The National Institute for Biotechnology in the Negev Ltd. |
Composition and method for treating amyotrophic lateral sclerosis
|
EP3400068A1
(en)
|
2016-01-06 |
2018-11-14 |
Yeda Research and Development Co., Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
WO2017122203A1
(en)
|
2016-01-11 |
2017-07-20 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
BR112018014902A2
(pt)
|
2016-01-21 |
2018-12-18 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
plantas partenocárpicas do tipo solanácea, frutos e sementes de uma planta, produtos processados comestíveis, métodos de produção e de reprodução de uma planta,
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
JP6883590B2
(ja)
|
2016-01-29 |
2021-06-09 |
ソレント・セラピューティクス・インコーポレイテッドSorrento Therapeutics, Inc. |
Pd−l1に結合する抗原結合性タンパク質
|
US11261433B2
(en)
|
2016-01-31 |
2022-03-01 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
RU2762089C2
(ru)
|
2016-02-04 |
2021-12-15 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
ПЕПТИДЫ И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ, НАРУШЕНИЙ ИЛИ СОСТОЯНИЙ, АССОЦИИРОВАННЫХ С МУТАНТНЫМ р53
|
US10036011B2
(en)
|
2016-02-11 |
2018-07-31 |
Qiagen Waltham, Inc. |
Scavenger compounds for improved sequencing-by-synthesis
|
US10337050B2
(en)
|
2016-02-11 |
2019-07-02 |
Qiagen Sciences, Llc |
Polyphenolic additives in sequencing by synthesis
|
WO2017138008A2
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
ES2771223T3
(es)
|
2016-02-14 |
2020-07-06 |
Yeda Res & Dev |
Diagnóstico, predicción y tratamiento de la obesidad recidivante basados en el microbioma
|
JP2019508422A
(ja)
|
2016-02-16 |
2019-03-28 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
シアノバクテリアおよび植物の増殖を阻害するための非タンパク質性フェニルアラニン類似体
|
WO2017147186A1
(en)
|
2016-02-22 |
2017-08-31 |
Ursure, Inc. |
System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
|
WO2017145162A1
(en)
|
2016-02-23 |
2017-08-31 |
Chaya Brodie |
Generation of cancer stem cells and use thereof
|
KR20180116377A
(ko)
|
2016-02-23 |
2018-10-24 |
더브테일 제노믹스 엘엘씨 |
게놈 어셈블리를 위한 페이징된 판독 세트의 생성 및 반수체형 페이징
|
BR112018015589A2
(pt)
|
2016-02-25 |
2019-10-01 |
Dupont Nutrition Biosci Aps |
método para produzir hidrolisado de proteína que emprega uma tripeptidil peptidase de aspergillus fumigatus
|
CN109071642B
(zh)
|
2016-02-26 |
2022-08-09 |
德克萨斯大学体系董事会 |
连接蛋白(Cx)43半通道结合抗体及其用途
|
SG11201807437XA
(en)
|
2016-03-01 |
2018-09-27 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Antibodies specific to human poliovirus receptor (pvr)
|
US20190085378A1
(en)
|
2016-03-03 |
2019-03-21 |
Memed Diagnostics Ltd. |
Analyzing rna for diagnosing infection type
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
LT3313423T
(lt)
|
2016-03-04 |
2019-06-25 |
4D Pharma Plc |
Kompozicijos, apimančios bakterinius blautia kamienus, skirtos visceralinio hiperjautrumo gydymui
|
WO2017153982A1
(en)
|
2016-03-06 |
2017-09-14 |
Yeda Research And Development Co. Ltd. |
Method for modulating myelination
|
CN109462996A
(zh)
|
2016-03-17 |
2019-03-12 |
西达-赛奈医疗中心 |
通过rnaset2诊断炎性肠病的方法
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
US10458995B2
(en)
|
2016-03-25 |
2019-10-29 |
Muralidhar Reddy Moola |
Combinatorial synthesis and biomarker development
|
MX2018011939A
(es)
|
2016-03-29 |
2019-05-20 |
Stcube Inc |
Anticuerpos de funcion doble especificos para pd-l1 glicosilada y metodos de uso de los mismos.
|
EP3436480A4
(en)
|
2016-03-30 |
2019-11-27 |
Musc Foundation for Research Development |
METHOD FOR THE TREATMENT AND DIAGNOSIS OF CANCER BY TARGETING GLYCOPROTEIN A REPETITION PREDOMINANT (GARP) AND FOR EFFECTIVE IMMUNOTHERAPY ALONE OR IN COMBINATION
|
DE202017007130U1
(de)
|
2016-04-27 |
2019-08-29 |
Gen-Probe Inc. |
Lysereagenz für Blutzellen
|
WO2017194589A1
(en)
|
2016-05-10 |
2017-11-16 |
Vib Vzw |
Inhibition of tau-mediated early synaptic dysfunction
|
IL262946B2
(en)
|
2016-05-13 |
2023-03-01 |
Dovetail Genomics Llc |
Retrieving long-range grip information from preserved samples
|
US11919971B2
(en)
|
2016-05-16 |
2024-03-05 |
President And Fellows Of Harvard College |
Aqueous biomolecule coupling on CO2-plasma-activated surfaces
|
CN109475581A
(zh)
|
2016-05-22 |
2019-03-15 |
耶达研究及发展有限公司 |
为了移植及诱导耐受性而使用肺细胞的方法
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
WO2017208247A1
(en)
|
2016-06-02 |
2017-12-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
WO2017214068A1
(en)
|
2016-06-05 |
2017-12-14 |
Berg Llc |
Systems and methods for patient stratification and identification of potential biomarkers
|
EP3464322B1
(en)
|
2016-06-05 |
2023-04-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Novel molecules for the treatment of inflammation
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
CN109689894A
(zh)
|
2016-06-19 |
2019-04-26 |
耶路撒冷希伯来大学伊萨姆研发有限公司 |
在人单倍体细胞中筛选化学疗法抗性
|
EP3475414A1
(en)
|
2016-06-27 |
2019-05-01 |
Yeda Research and Development Co. Ltd |
Veto cells generated from memory t cells
|
US11125744B2
(en)
|
2016-06-30 |
2021-09-21 |
Siemens Healthineers Nederland B.V. |
Device, system and method for detecting an analyte in a body fluid sample containing a plurality of cells
|
EP3482200B1
(en)
|
2016-07-10 |
2022-05-04 |
Memed Diagnostics Ltd. |
Protein signatures for distinguishing between bacterial and viral infections
|
US11340223B2
(en)
|
2016-07-10 |
2022-05-24 |
Memed Diagnostics Ltd. |
Early diagnosis of infections
|
CA3030533A1
(en)
|
2016-07-11 |
2018-01-18 |
Oren HERSHKOVITZ |
Long-acting coagulation factor vii and methods of producing same
|
US20200080050A1
(en)
|
2016-07-11 |
2020-03-12 |
Yaakov Nahmias |
Systems and methods for growing cells in vitro
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
WO2018011804A1
(en)
|
2016-07-11 |
2018-01-18 |
Bonus Therapeutics Ltd. |
Cell compositions for tissue regeneration
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
AU2017300579B2
(en)
|
2016-07-20 |
2023-02-09 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Therapeutic agents for neurological and psychiatric disorders
|
JP2019528251A
(ja)
|
2016-07-20 |
2019-10-10 |
エスティーキューブ,インコーポレイテッド |
グリコシル化pd−l1に結合する抗体の組合せを使用するがんの処置および治療の方法
|
WO2018020489A1
(en)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
ES2965761T3
(es)
|
2016-08-08 |
2024-04-16 |
Tech Innovation Momentum Fund Israel Limited Partnership |
Sistemas bacterianos para el análisis de polipéptidos ubiquitilados
|
EP3497239A4
(en)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
METHYLATION STATUS ANALYSIS AND COPY NUMBER
|
WO2018029690A1
(en)
|
2016-08-10 |
2018-02-15 |
Memed Diagnostics Ltd. |
System and method for analysis of biological data
|
IL264825B
(en)
|
2016-08-14 |
2022-08-01 |
Univ Ramot |
Exosomes from mesenchymal cells for the treatment of neurological diseases
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
JP2020501506A
(ja)
|
2016-09-07 |
2020-01-23 |
イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー. |
抗NKp46抗体およびその治療的使用
|
EP3512943B1
(en)
|
2016-09-14 |
2023-04-12 |
Yeda Research and Development Co. Ltd. |
Crisp-seq, an integrated method for massively parallel single cell rna-seq and crispr pooled screens
|
US11385241B2
(en)
|
2016-09-29 |
2022-07-12 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
EP3535409B1
(en)
|
2016-11-04 |
2024-03-20 |
CD Diagnostics, Inc. |
Direct detection of microorganisms in patient samples by immunoassay
|
WO2018089231A1
(en)
|
2016-11-09 |
2018-05-17 |
Qiagen Sciences Llc |
Photoprotective mixtures as imaging reagents in sequencing-by-synthesis
|
EP3538651A1
(en)
|
2016-11-10 |
2019-09-18 |
Yeda Research and Development Co., Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
RU2765737C2
(ru)
|
2016-11-23 |
2022-02-02 |
Хемоцентрикс, Инк. |
Способ лечения фокально-сегментарного гломерулосклероза
|
JP2019535298A
(ja)
|
2016-11-28 |
2019-12-12 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
単離ポリヌクレオチドおよびポリペプチドおよび関心のある発現産物を発現させるためにそれらを使用する方法
|
EP3548637A1
(en)
|
2016-11-29 |
2019-10-09 |
Genomic Vision |
Method for designing a set of polynucleotide sequences for analysis of specific events in a genetic region of interest
|
EP3548015A1
(en)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
EP3548106B1
(en)
|
2016-12-01 |
2023-01-04 |
Ramot at Tel-Aviv University Ltd. |
Combined treatment for nerve injuries
|
EP3329905A1
(en)
|
2016-12-05 |
2018-06-06 |
Nuritas Limited |
Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin
|
EP3329930A1
(en)
|
2016-12-05 |
2018-06-06 |
Nuritas Limited |
Pharmaceuctical compositions
|
JP2020504714A
(ja)
|
2016-12-05 |
2020-02-13 |
ニューリタス リミテッド |
ペプチドwkdeagkplvkを含む組成物
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
CN110392736A
(zh)
|
2017-01-18 |
2019-10-29 |
耶达研究及发展有限公司 |
遗传修饰的反抑细胞及其在免疫治疗中的用途
|
US20190390278A1
(en)
|
2017-01-26 |
2019-12-26 |
Oklahoma Medical Research Foundation |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
KR102607101B1
(ko)
|
2017-01-26 |
2023-11-29 |
제트엘아이피 홀딩 리미티드 |
Cd47 항원 결합 유닛 및 그것의 사용
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
WO2018146162A1
(en)
|
2017-02-07 |
2018-08-16 |
Academisch Medisch Centrum |
Molecular biomarker for prognosis of sepsis patients
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
US11179413B2
(en)
|
2017-03-06 |
2021-11-23 |
Novartis Ag |
Methods of treatment of cancer with reduced UBB expression
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
EP3596469A1
(en)
|
2017-03-12 |
2020-01-22 |
Yeda Research and Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
JP2020511539A
(ja)
|
2017-03-16 |
2020-04-16 |
リネージ セル セラピューティクス インコーポレイテッド |
網膜疾患治療法の治療効果を測定する方法
|
JP2020516243A
(ja)
|
2017-04-05 |
2020-06-11 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
エクスビボ培養系およびその使用方法
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
EP3621991A2
(en)
|
2017-05-10 |
2020-03-18 |
Ariel Scientific Innovations Ltd. |
Methods of purifying antibodies
|
US11714089B2
(en)
|
2017-05-21 |
2023-08-01 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Combination of markers for diagnosing cancer
|
RS61872B1
(sr)
|
2017-05-22 |
2021-06-30 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
EP3634991A1
(en)
|
2017-05-23 |
2020-04-15 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
EP3630942B1
(en)
|
2017-05-24 |
2022-11-30 |
4D Pharma Research Limited |
Compositions comprising bacterial strain
|
WO2018222685A1
(en)
|
2017-05-31 |
2018-12-06 |
Stcube & Co., Inc. |
Methods of treating cancer using antibodies and molecules that immunospecifically bind to btn1a1
|
EP3630973A1
(en)
|
2017-05-31 |
2020-04-08 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
US20200148768A1
(en)
|
2017-05-31 |
2020-05-14 |
Stcube & Co., Inc. |
Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
KR20200026209A
(ko)
|
2017-06-06 |
2020-03-10 |
주식회사 에스티큐브앤컴퍼니 |
Btn1a1 또는 btn1a1-리간드에 결합하는 항체 및 분자를 사용하여 암을 치료하는 방법
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
EP3638271B1
(en)
|
2017-06-14 |
2020-10-14 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
AU2018285453B2
(en)
|
2017-06-14 |
2020-03-19 |
Cj Bioscience, Inc. |
Compositions comprising a bacterial strain of the genus Megasphaera and uses thereof
|
US11466323B2
(en)
|
2017-07-13 |
2022-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Dual-probe digital droplet PCR strategy for specific detection of tissue-specific circulating DNA molecules
|
WO2019012543A1
(en)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
DNA TARGETS AS SPECIFIC TISSUE METHYLATION MARKERS
|
EP3652342A1
(en)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Detecting tissue-specific dna
|
WO2019018747A1
(en)
|
2017-07-20 |
2019-01-24 |
Trustees Of Boston University |
DETECTION ASSAY OF TENOFOVIR
|
WO2019016772A2
(en)
|
2017-07-21 |
2019-01-24 |
Novartis Ag |
COMPOSITIONS AND METHODS FOR TREATING CANCER
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
WO2019038771A1
(en)
|
2017-08-23 |
2019-02-28 |
Technion Research & Development Foundation Limited |
COMPOSITIONS AND METHODS FOR ENHANCING ALCOHOL TOLERANCE IN YEAST
|
US11306144B2
(en)
|
2017-08-25 |
2022-04-19 |
Five Prime Therapeutics, Inc. |
B7-H4 antibodies and methods of use thereof
|
EP3626745A4
(en)
|
2017-09-01 |
2021-03-17 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
RECOMBINANT BISPECIFIC ANTIBODY
|
JP7365704B2
(ja)
|
2017-09-05 |
2023-10-20 |
グラディエーター バイオサイエンシーズ インコーポレイテッド |
幹細胞へのペイロードの送達
|
GB2581619A
(en)
|
2017-09-15 |
2020-08-26 |
Univ California |
Inhibition of aminoacylase 3 (AA3) in the treatment of cancer
|
KR20200051808A
(ko)
|
2017-09-19 |
2020-05-13 |
트로픽 바이오사이언시즈 유케이 리미티드 |
진핵 세포에서 유전자 발현을 침묵시키기 위한 비-암호화 rna 분자의 특이성의 변형
|
US20200255828A1
(en)
|
2017-10-04 |
2020-08-13 |
The Broad Institute, Inc. |
Methods and compositions for altering function and structure of chromatin loops and/or domains
|
CA3078809A1
(en)
|
2017-10-11 |
2019-04-18 |
Chemocentryx, Inc. |
Treatment of focal segmental glomerulosclerosis with ccr2 antagonists
|
EP3694545A4
(en)
|
2017-10-11 |
2021-12-01 |
Board Of Regents, The University Of Texas System |
HUMAN PD-L1 ANTIBODIES AND METHOD OF USING THEM
|
AU2018364630A1
(en)
|
2017-11-09 |
2020-05-21 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
US20200390800A1
(en)
|
2017-11-29 |
2020-12-17 |
Ramot At Tel-Aviv University Ltd. |
Methods of preventing or treating neurogenic shock
|
BR112020010830A2
(pt)
|
2017-11-29 |
2020-11-10 |
Weedout Ltd. |
composições, kits e métodos para controlar erva daninha do gênero amaranthus
|
WO2019106680A1
(en)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Treatment of an ischemic heart disease
|
CN109870581B
(zh)
|
2017-12-04 |
2021-05-04 |
厦门万泰凯瑞生物技术有限公司 |
一种定量检测HBsAg的试剂盒及方法
|
CN111465406A
(zh)
|
2017-12-15 |
2020-07-28 |
先正达参股股份有限公司 |
用于检测靶蛋白的非抗体配体
|
EP3723785A1
(en)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Cop9 signalosome (csn) complex modulators and uses thereof
|
EP3731965A1
(en)
|
2017-12-28 |
2020-11-04 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Method to reproduce circadian rhythms on a microfluidic chip
|
WO2019156758A2
(en)
|
2018-01-05 |
2019-08-15 |
Vanderbilt University |
Antibody-mediated neutralization of chikungunya virus
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
EP3749689A1
(en)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Inhibitors of the 20s proteasome
|
WO2019155465A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
WO2019165217A1
(en)
|
2018-02-22 |
2019-08-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cd153 and/or cd30 in infection
|
US11571433B2
(en)
|
2018-02-23 |
2023-02-07 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
WO2019167047A1
(en)
|
2018-02-28 |
2019-09-06 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
JP2021516051A
(ja)
|
2018-03-02 |
2021-07-01 |
ファイブ プライム セラピューティクス, インコーポレイテッド |
B7−h4抗体及びその使用方法
|
EP3765034A1
(en)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Treatment of a heart disease
|
WO2019182896A1
(en)
|
2018-03-23 |
2019-09-26 |
Board Of Regents, The University Of Texas System |
Dual specificity antibodies to pd-l1 and pd-l2 and methods of use therefor
|
JP2021519283A
(ja)
|
2018-03-29 |
2021-08-10 |
テクニオン・リサーチ・アンド・ディベロップメント・ファウンデーション・リミテッド |
Pten阻害剤を含む小胞およびその使用
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
EP3774047A1
(en)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Use of electric field gradients to control gene expression
|
EP4063519B1
(en)
|
2018-04-09 |
2023-09-13 |
Advanced Cell Diagnostics, Inc. |
Methods to further enhance signal amplification for the in situ detection of nucleic acids
|
EP3785732A4
(en)
|
2018-04-24 |
2022-02-23 |
Ampsource Biopharma Shanghai Inc. |
ANTIBODIES AGAINST TIM-3 AND USE THEREOF
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
EP3788138A1
(en)
|
2018-05-02 |
2021-03-10 |
Novartis AG |
Regulators of human pluripotent stem cells and uses thereof
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
AU2019277908A1
(en)
|
2018-05-27 |
2021-01-07 |
Biolinerx Ltd. |
AGI-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
US20210337753A1
(en)
|
2018-06-07 |
2021-11-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Methods of regenerating and transforming cannabis
|
WO2019234754A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
WO2019238962A1
(en)
|
2018-06-14 |
2019-12-19 |
University College Cork - National University Of Ireland, Cork |
Peptide for disease treatment
|
TW202016144A
(zh)
|
2018-06-21 |
2020-05-01 |
日商第一三共股份有限公司 |
包括cd3抗原結合片段之組成物及其用途
|
EP3810636A1
(en)
|
2018-06-25 |
2021-04-28 |
Yeda Research and Development Co. Ltd |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
US20210269860A1
(en)
|
2018-07-08 |
2021-09-02 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
WO2020012486A1
(en)
|
2018-07-11 |
2020-01-16 |
Kahr Medical Ltd. |
SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
|
SG11202012773QA
(en)
|
2018-07-11 |
2021-01-28 |
Immunity Pharma Ltd |
Peptide compounds and therapeutic uses of same
|
EP3827087A1
(en)
|
2018-07-31 |
2021-06-02 |
CollPlant Ltd. |
Tobacco transgenic event and methods for detection and use thereof
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
WO2020039440A1
(en)
|
2018-08-24 |
2020-02-27 |
Yeda Research And Development Co. Ltd. |
Methods of modulating m2 macrophage polarization and use of same in therapy
|
AU2019339469A1
(en)
|
2018-09-13 |
2021-03-11 |
Immune-Onc Therapeutics, Inc. |
Novel LILRB4 antibodies and uses thereof
|
WO2020058979A2
(en)
|
2018-09-20 |
2020-03-26 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral sclerosis
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
CN113195511A
(zh)
|
2018-09-28 |
2021-07-30 |
生捷科技控股公司 |
二硫键连接的可逆终止剂
|
CA3116555A1
(en)
|
2018-10-15 |
2020-04-23 |
University Of Massachusetts |
Programmable dna base editing by nme2cas9-deaminase fusion proteins
|
CA3116539C
(en)
|
2018-10-18 |
2023-10-03 |
Oklahoma Medical Research Foundation |
Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
|
BR112021007690A2
(pt)
|
2018-10-22 |
2021-08-10 |
Shanghai GenBase Biotechnology Co., Ltd. |
anticorpo anti-cldn18.2 e uso do mesmo
|
JP2022506108A
(ja)
|
2018-10-23 |
2022-01-17 |
グリカルディアル ダイアグノスティクス エセ. エレ. |
グリコシル化ApoJに特異的な抗体およびその使用
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
CN111196851B
(zh)
|
2018-11-20 |
2021-11-16 |
厦门万泰凯瑞生物技术有限公司 |
针对人抗缪勒管激素的特异性抗体及其应用
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
WO2020113084A1
(en)
|
2018-11-28 |
2020-06-04 |
Oregon Health & Science University |
Therapeutic factor xii antibody
|
WO2020113237A1
(en)
|
2018-11-30 |
2020-06-04 |
Caris Mpi, Inc. |
Next-generation molecular profiling
|
CN113166246A
(zh)
|
2018-12-28 |
2021-07-23 |
四川科伦博泰生物医药股份有限公司 |
一种抗体及其用途
|
WO2020152686A1
(en)
|
2019-01-23 |
2020-07-30 |
Yeda Research And Development Co. Ltd. |
Culture media for pluripotent stem cells
|
US20220056498A1
(en)
|
2019-01-25 |
2022-02-24 |
President And Fellows Of Harvard College |
Compositions and method for synthesizing nucleic acids
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
US20220154262A1
(en)
|
2019-02-15 |
2022-05-19 |
Advanced Cell Diagnostics, Inc. |
Methods for multiplex detection of nucleic acids by in situ hybridization
|
WO2020170240A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reduction drug-induced nephrotoxicity
|
WO2020170239A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
IL286011B1
(en)
|
2019-03-05 |
2024-02-01 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Genome-edited birds
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
EP3946611A2
(en)
|
2019-03-31 |
2022-02-09 |
Yeda Research and Development Co. Ltd |
Anti-viral and anti-tumoral compounds
|
CN113474374A
(zh)
|
2019-04-16 |
2021-10-01 |
四川科伦博泰生物医药股份有限公司 |
抗FXI/FXIa抗体及其用途
|
AU2020265250A1
(en)
|
2019-04-30 |
2021-11-18 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
WO2020230133A1
(en)
|
2019-05-13 |
2020-11-19 |
Yeda Research And Development Co. Ltd. |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
CA3140611A1
(en)
|
2019-05-22 |
2020-11-26 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
IT201900007222A1
(it)
|
2019-05-24 |
2020-11-24 |
Univ Degli Studi Di Torino |
Composizione di liposomi e metodo di dosaggio basato sull'uso degli stessi
|
GB2598520A
(en)
|
2019-05-28 |
2022-03-02 |
Univ Shanghai Tech |
Composition and methods to treat ectodermal dysplasia 2, Clouston type
|
WO2020250232A1
(en)
|
2019-06-12 |
2020-12-17 |
Hadasit Medical Research Services And Development Ltd. |
Methods of generating oligodendrocytes
|
WO2020255124A1
(en)
|
2019-06-16 |
2020-12-24 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
WO2020261281A1
(en)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
JP2022538647A
(ja)
|
2019-07-04 |
2022-09-05 |
ウッコ インコーポレイテッド |
脱エピトープ化されたアルファグリアジン、ならびにセリアック病およびグルテン過敏症の管理のためのその使用
|
US20220267409A1
(en)
|
2019-07-11 |
2022-08-25 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
WO2021009740A1
(en)
|
2019-07-16 |
2021-01-21 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
CN114555807A
(zh)
|
2019-07-19 |
2022-05-27 |
费城儿童医院 |
包含磷脂酰肌醇蛋白聚糖2结合结构域的嵌合抗原受体
|
EP4004037A1
(en)
|
2019-07-26 |
2022-06-01 |
Vanderbilt University |
Human monoclonal antibodies to enterovirus d68
|
EP4004548A1
(en)
|
2019-07-29 |
2022-06-01 |
Yeda Research and Development Co. Ltd |
Methods of treating and diagnosing lung cancer
|
WO2021019536A1
(en)
|
2019-07-30 |
2021-02-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
EP4014046A1
(en)
|
2019-08-12 |
2022-06-22 |
Yeda Research and Development Co. Ltd |
Dna repair blood test for predicting response of lung cancer patients to immunotherapy
|
BR112022002727A2
(pt)
|
2019-08-20 |
2022-08-23 |
Nuritas Ltd |
Peptídeos para tratamento de atrofia muscular
|
EP3783012A1
(en)
|
2019-08-20 |
2021-02-24 |
Nuritas Limited |
An antimicrobial peptide
|
WO2021033176A1
(en)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
EP4021463A1
(en)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Treatment of bacterial vaginosis
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
EP4032907A4
(en)
|
2019-09-20 |
2023-07-05 |
Shanghai Genbase Biotechnology Co., Ltd. |
BCMA-TARGETING CHEMERA ANTIGENIC ANTIBODIES AND RECEPTOR
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
EP4041767A1
(en)
|
2019-09-26 |
2022-08-17 |
StCube & Co. |
Antibodies specific to glycosylated ctla-4 and methods of use thereof
|
KR20220070201A
(ko)
|
2019-09-30 |
2022-05-30 |
쓰촨 케룬-바이오테크 바이오파마수티컬 컴퍼니 리미티드 |
항-pd-1 항체 및 이의 용도
|
JP2022552282A
(ja)
|
2019-10-09 |
2022-12-15 |
エスティーキューブ アンド カンパニー |
グリコシル化lag3に対して特異的な抗体およびその使用方法
|
CN114980913A
(zh)
|
2019-10-22 |
2022-08-30 |
努里塔斯有限公司 |
非酒精性脂肪性肝病的治疗
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
WO2021084526A1
(en)
|
2019-10-31 |
2021-05-06 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
US20220386594A1
(en)
|
2019-11-11 |
2022-12-08 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
AU2019474716A1
(en)
|
2019-11-19 |
2022-07-07 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
US10792360B1
(en)
|
2019-11-21 |
2020-10-06 |
Chemocentryx, Inc. |
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
|
EP4069865A4
(en)
|
2019-12-02 |
2023-12-20 |
Caris MPI, Inc. |
PLATINUM RESISTANCE TEST FOR PAN CANCER
|
JP2023506176A
(ja)
|
2019-12-12 |
2023-02-15 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
光誘導型生体分子バーコーディングのための組成物および方法
|
EP4047019A4
(en)
|
2019-12-13 |
2023-11-15 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
ANTI-TSLP ANTIBODIES AND USES THEREOF
|
AU2020409124A1
(en)
|
2019-12-20 |
2022-06-30 |
Novarock Biotherapeutics, Ltd. |
Anti-interleukin-23 p19 antibodies and methods of use thereof
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
EP4077731A1
(en)
|
2019-12-22 |
2022-10-26 |
Yeda Research and Development Co. Ltd |
Diagnosis of frontotemporal dementia
|
EP3842452A1
(en)
|
2019-12-26 |
2021-06-30 |
Universitat Autònoma de Barcelona |
Scaffold proteins and therapeutic nanoconjugates based on nidogen
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
US20230048361A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
US20230048719A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
CN113061165A
(zh)
|
2020-01-02 |
2021-07-02 |
厦门大学 |
EB病毒BNLF2b基因编码多肽及其检测用途
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
WO2021152587A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Treating acute liver disease with tlr-mik inhibitors
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
CN115087668A
(zh)
|
2020-01-31 |
2022-09-20 |
奥斯瓦道·克鲁兹基金会 |
抗体、其用途、药物组合物,包括真菌感染诊断方法、真菌感染诊断试剂盒和真菌感染治疗方法
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
EP3862014A1
(en)
|
2020-02-07 |
2021-08-11 |
Nuritas Limited |
Treatment of panx1 associated diseases
|
JP2023513334A
(ja)
|
2020-02-09 |
2023-03-30 |
エヌエルシー ファーマ リミテッド |
Sars-cov-2の迅速検出検査
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
WO2021163265A1
(en)
|
2020-02-11 |
2021-08-19 |
Vanderbilt University |
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (sars-cov- 2)
|
WO2021167908A1
(en)
|
2020-02-17 |
2021-08-26 |
Board Of Regents, The University Of Texas System |
Methods for expansion of tumor infiltrating lymphocytes and use thereof
|
WO2021170540A1
(en)
|
2020-02-25 |
2021-09-02 |
Vib Vzw |
Leucine-rich repeat kinase 2 allosteric modulators
|
WO2021173674A1
(en)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
US20230127559A1
(en)
|
2020-03-16 |
2023-04-27 |
Yeda Research And Development Co. Ltd. |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with mutant p53 protein
|
WO2021195385A1
(en)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-GoV-2)
|
PT4045533T
(pt)
|
2020-03-26 |
2024-02-14 |
Univ Vanderbilt |
Anticorpos monoclonais humanos para síndrome respiratória aguda grave coronavírus 2 (sars-cov-2)
|
JP2023519934A
(ja)
|
2020-03-29 |
2023-05-15 |
イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド |
ゴーシェ病の処置において使用するためのベータ-グルコセレブロシダーゼのバリアント
|
CA3175870A1
(en)
|
2020-03-31 |
2021-10-07 |
Biomuse Ltd. |
Bacteria for the prevention and treatment of smoke-induced lung damage
|
TW202203916A
(zh)
|
2020-03-31 |
2022-02-01 |
美商卡默森屈有限公司 |
使用ccr9抑制劑及抗il—23阻斷抗體治療發炎性腸道疾病的組成物及方法
|
EP4133107A1
(en)
|
2020-04-06 |
2023-02-15 |
Yeda Research and Development Co. Ltd |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
EP4132479A1
(en)
|
2020-04-07 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Cannabidiol-containing compositions and uses thereof
|
AU2021255132A1
(en)
|
2020-04-13 |
2022-12-08 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type P53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
CN116096884A
(zh)
|
2020-04-22 |
2023-05-09 |
哈佛大学校长及研究员协会 |
用于检测核酸的恒温方法、组合物、试剂盒和系统
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
IL298184A
(en)
|
2020-05-15 |
2023-01-01 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
Antibody conjugates with a drug, a method for their preparation and their use
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
CN115803062A
(zh)
|
2020-06-03 |
2023-03-14 |
博泰康医药公司 |
滋养层细胞表面抗原2(trop-2)抗体
|
WO2021260675A1
(en)
|
2020-06-24 |
2021-12-30 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
EP3939999A1
(en)
|
2020-07-14 |
2022-01-19 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Interleukin 11 receptor alpha subunit (il11ra) neutralizing antibodies and uses thereof
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
WO2022038536A1
(en)
|
2020-08-18 |
2022-02-24 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
WO2022047359A1
(en)
|
2020-08-31 |
2022-03-03 |
Berg Llc |
Protein biomarkers for pancreatic cancer
|
KR20230060509A
(ko)
|
2020-09-04 |
2023-05-04 |
노바록 바이오테라퓨틱스 리미티드 |
넥틴-4 항체 및 이의 용도
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
EP4217370A2
(en)
|
2020-09-23 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Methods and compositions for treating coronaviral infections
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
WO2022074646A1
(en)
|
2020-10-05 |
2022-04-14 |
Protalix Ltd. |
Dicer-like knock-out plant cells
|
EP4225903A1
(en)
|
2020-10-07 |
2023-08-16 |
Protalix Ltd. |
Long-acting dnase
|
WO2022079719A1
(en)
|
2020-10-15 |
2022-04-21 |
Yeda Research And Development Co. Ltd. |
Method of treating myeloid malignancies
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
AU2021374966A1
(en)
|
2020-11-09 |
2023-06-15 |
1E Therapeutics, Ltd. |
Catalytic sequence based methods of treating or preventing bacterial infections
|
GB202105804D0
(en)
|
2020-11-20 |
2021-06-09 |
Univ Cape Town |
Use of microvirin in the identification of mycobacterium tuberculosis mannose-capped lipoarabinomannan
|
AU2021387979A1
(en)
|
2020-11-26 |
2023-03-30 |
Ukko Inc. |
Modified high molecular weight glutenin subunit and uses thereof
|
US20240003912A1
(en)
|
2020-12-04 |
2024-01-04 |
University Of Tennessee Research Foundation |
Method for diagnosing amyloid diseases
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
IL304068A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
DNA enzymes against p21 messenger RNA
|
WO2022144882A2
(en)
|
2020-12-28 |
2022-07-07 |
1E Therapeutics, Ltd. |
P21 mrna target areas for silencing
|
CN117043189A
(zh)
|
2020-12-31 |
2023-11-10 |
诺纳生物(苏州)有限公司 |
人lifr抗原结合蛋白及其制备方法和应用
|
JP2024502377A
(ja)
|
2021-01-10 |
2024-01-18 |
スーパーミート ザ エッセンス オブ ミート リミテッド |
培養肉産業用の多能性幹細胞凝集体及びそれから得られる微小組織
|
WO2022153286A1
(en)
|
2021-01-14 |
2022-07-21 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
EP4281484A1
(en)
|
2021-01-22 |
2023-11-29 |
Bionecure Therapeutics, Inc. |
Anti-her-2/trop-2 constructs and uses thereof
|
GB2603166A
(en)
|
2021-01-29 |
2022-08-03 |
Thelper As |
Therapeutic and Diagnostic Agents and Uses Thereof
|
KR20230145038A
(ko)
|
2021-02-09 |
2023-10-17 |
메디링크 테라퓨틱스 (쑤저우) 컴퍼니, 리미티드 |
생물활성 물질 접합체, 이의 제조방법 및 이의 용도
|
JP2024506955A
(ja)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ワクチンを作製する方法
|
JP2024506954A
(ja)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ワクチン作製用の遺伝子改変細菌
|
EP4294516A1
(en)
|
2021-02-19 |
2023-12-27 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
JP2024512337A
(ja)
|
2021-03-05 |
2024-03-19 |
シャンハイ、ケンパーソー、バイオテクノロジー、カンパニー、リミテッド |
抗cldn6抗体およびその使用
|
TW202302155A
(zh)
|
2021-03-08 |
2023-01-16 |
美商伊繆諾金公司 |
用於增加靶向adam9之免疫結合物治療癌症之功效的方法
|
MX2023008176A
(es)
|
2021-03-09 |
2023-07-18 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
Proteina de union a ror1 y uso de la misma.
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
WO2022208369A1
(en)
|
2021-03-30 |
2022-10-06 |
Biomx Ltd. |
Pseudomonas bacteriophage and uses thereof
|
CA3214833A1
(en)
|
2021-04-06 |
2022-10-13 |
Bpgbio, Inc. |
Protein markers for the prognosis of breast cancer progression
|
CA3214821A1
(en)
|
2021-04-06 |
2022-10-13 |
Guisong WANG |
Protein markers for estrogen receptor (er)-positive-like and estrogen receptor (er)-negative-like breast cancer
|
EP4320440A1
(en)
|
2021-04-06 |
2024-02-14 |
BPGbio, Inc. |
Protein markers for estrogen receptor (er)-positive luminal a(la)-like and luminal b1 (lb1)-like breast cancer
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
AU2022259536A1
(en)
|
2021-04-14 |
2023-11-09 |
University College Cork - National University Of Ireland, Cork |
Treatment of cerebrovascular events and neurological disorders
|
CA3214579A1
(en)
|
2021-04-14 |
2022-10-20 |
Tom Moore |
Psg1 for use in the treatment of osteoarthritis
|
JP2024515726A
(ja)
|
2021-04-19 |
2024-04-10 |
テンプル セラピューティクス ビーブイ |
子宮内膜過剰増殖性障害および卵巣過剰増殖性障害を検出または処置するための方法
|
EP4337764A1
(en)
|
2021-05-12 |
2024-03-20 |
Biomx Ltd. |
Staphylococcus bacteriophage and uses thereof
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
IL309061A
(en)
|
2021-06-06 |
2024-02-01 |
Yeda res & development co ltd |
Combined cancer treatment
|
EP4355857A1
(en)
|
2021-06-13 |
2024-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Method for reprogramming human cells
|
CR20240020A
(es)
|
2021-06-16 |
2024-02-28 |
Seedx Tech Inc |
Métodos de clasificación de semillas de matthiola
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
CA3223344A1
(en)
|
2021-07-02 |
2023-01-05 |
Tropic Biosciences UK Limited |
Delay or prevention of browning in banana fruit
|
WO2023288046A1
(en)
|
2021-07-15 |
2023-01-19 |
President And Fellows Of Harvard College |
Compositions and methods relating to cells with adhered particles
|
WO2023003809A1
(en)
|
2021-07-18 |
2023-01-26 |
Gamida-Cell Ltd. |
Therapeutic nk cell populations
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
CA3228014A1
(en)
|
2021-07-30 |
2023-02-16 |
Vib Vzm |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
WO2023012798A2
(en)
|
2021-08-02 |
2023-02-09 |
Yeda Research And Development Co. Ltd. |
Antibodies for the treatment of cancer
|
WO2023012584A2
(en)
|
2021-08-03 |
2023-02-09 |
Genicity Limited |
Engineered tcr complex and methods of using same
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
WO2023018621A1
(en)
|
2021-08-10 |
2023-02-16 |
Gamida-Cell Ltd. |
Engineered nk cells, methods of their production and uses thereof
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
WO2023081070A1
(en)
|
2021-11-02 |
2023-05-11 |
University Of Massachusetts |
Nme2Cas9 INLAID DOMAIN FUSION PROTEINS
|
TW202323301A
(zh)
|
2021-11-19 |
2023-06-16 |
英商米羅比奧有限公司 |
經工程改造之pd-1抗體及其用途
|
WO2023105526A1
(en)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Multipotent lung progenitor cells for lung regeneration
|
GB202201137D0
(en)
|
2022-01-28 |
2022-03-16 |
Thelper As |
Therapeutic and diagnostic agents and uses thereof
|
WO2023144798A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
EP4238988A1
(en)
|
2022-03-01 |
2023-09-06 |
Consejo Superior De Investigaciones Científicas |
Antibodies against sars-cov-2 and uses thereof
|
WO2023192976A1
(en)
|
2022-04-01 |
2023-10-05 |
Board Of Regents, The University Of Texas System |
Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor
|
GB202204813D0
(en)
|
2022-04-01 |
2022-05-18 |
Bradcode Ltd |
Human monoclonal antibodies and methods of use thereof
|
US20230416361A1
(en)
|
2022-04-06 |
2023-12-28 |
Mirobio Limited |
Engineered cd200r antibodies and uses thereof
|
WO2023196937A1
(en)
|
2022-04-06 |
2023-10-12 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring frataxin replacement therapy
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|
WO2023239710A1
(en)
|
2022-06-08 |
2023-12-14 |
Onkure, Inc. |
Benzopyrimidin-4(3h)-ones as pi3k inhibitors
|
WO2023240201A1
(en)
|
2022-06-08 |
2023-12-14 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring progression and treatment of leigh syndrome
|
US20240010742A1
(en)
|
2022-06-10 |
2024-01-11 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
WO2024028794A1
(en)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Methods for treating endometrial and ovarian hyperproliferative disorders
|
WO2024040020A1
(en)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Quantitative affinity activity specific cell enrichment
|
WO2024038160A1
(en)
|
2022-08-18 |
2024-02-22 |
Vib Vzw |
Means and methods to modulate neuron excitability
|
WO2024054469A1
(en)
|
2022-09-08 |
2024-03-14 |
Onkure, Inc. |
Isoquinolones as pi3k inhibitors
|
WO2024064024A1
(en)
|
2022-09-19 |
2024-03-28 |
Onkure, Inc. |
((4-oxo-3,4-dihydroquinazolin-8-yl)methyl)amine derivatives as p13k inhibitors for the treatment of cancer
|
WO2024064002A1
(en)
|
2022-09-20 |
2024-03-28 |
Onkure, Inc. |
Hdac inhibitor oki-179 for the treatment of cancers resulting from a mapk pathway mutation
|
WO2024068744A1
(en)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antivirals against human parainfluenza virus
|
WO2024078729A1
(en)
|
2022-10-14 |
2024-04-18 |
University College Cork - National University Of Ireland, Cork |
Placenta expressed proteins for use in the treatment of tendon injury
|
WO2024081345A1
(en)
|
2022-10-14 |
2024-04-18 |
Onkure, Inc. |
Benzopyrimidin-4(3h)-ones as pi3k inhibitors
|